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1. Introduction 
1.1 Background of the study 
Gold nanoparticles (AuNPs) attract the interest of scientists due to their promising 
potential applications in biomedical engineering such as vector of antisense cancer 
drugs, agent for molecular imaging, and targeting reagent in cancer therapy. One of 
the arguments to use gold nanoparticles (AuNPs) in vivo is that gold in bulk form is 
nontoxic. Bulk gold is century-long accepted as a safe-to-use metal and has well 
functioned in anti-rheumatoid arthritis medication and as dental prosthesis. In 
comparison to the gold in bulk form, AuNPs have distinct chemical and physical 
properties and the large amount of surface atoms make AuNPs reactive. Moreover, 
AuNPs can potentially access many cellular or subcellular structures, which are 
unreachable by the larger compound and may induce toxic effects. 
 
In the last 5 years, major organizations and agencies including World Health 
Organization (WHO), Food and Drug Administration (FDA) and European Medicines 
Agency (EMEA) have realized the importance to establish a framework to evaluate 
the safety of engineered nanomaterials (ENM). The safety and ethical considerations 
for nanotechnology were presented in reports like the “nanotechnology task force 
reports”1 issued in 2007 and “reflection paper on nanotechnology-based medicinal 
products for human use”2. These reports momentously emphasized the importance 
of nanotechnology safety studies. Most of the considerations focus on the accuracy 
of the existing toxicological methods and the assessment of the hazards of 
engineered nanoproducts. The European commission has requested independent 
experts of scientific committees on emerging and newly identified health risks 
(SCENIHR) to evaluate the appropriateness of existing methodologies to assess the 
potential risks of nanomaterials 3. To date, the official guidelines for the assessment 
are still missing which makes comparisons of toxicity results among different groups 
difficult and the conclusion about the toxicity of AuNPs is still controversial.  
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1.2 Nomenclature, composition and quantification of gold 
nanoparticles 
1.2.1 Nanoparticles, clusters and colloids 
Nanoparticles define particles with a diameter less than 100 nm. It is a relatively 
broad definition compared to cluster and colloid. Colloids are used to name those 
nanoparticles of a size larger than 10 nm. Clusters are usually applied to nominate 
those particles with a diameter less than 10 nm, which have well-defined chemical 
and structural properties including number of atoms, ligands, crystal arrangement 
and atom-ligand coordination 4.  
 
1.2.2 Composition of gold nanoparticles  
Gold nanoparticles consist of a core of gold atoms and ligand layers connected 
through a bond as shown in figure 1. The parameters used to describe the atom core 
include the number of atoms, atomic arrangement and diameter. In most of the cases 
when it is not specifically emphasized, the size of the nanoparticle describes the 
diameter of the atom core. Naked nanoparticles are not stable in solutions. Therefore, 
to avoid aggregation, AuNPs are further stabilized with one or more ligand layers. 
The surface modification, on one side stabilizes the nanoparticle and on the other 
side, gives those metallic atoms different properties depending on the position of the 
atoms and their ligand binding 4.  
 
Figure 1 Model of Au cluster with the triphenylphosphine derivative ligand. Not drawn to size. 
The gold nanoparticle consists of a core of gold atoms (Au), and ligands connected through gold-
phosphor bonds. 
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1.2.3 Quantification of AuNPs and its influence on toxicity evaluation  
1.2.3.1 Comparing AuNPs toxicity 
Comparing the gold nanoparticle toxicity results from different work groups is difficult. 
One of the reasons is that the units describing the concentration of AuNPs in 
literatures are not identical. Some groups use nanoparticle molarity without exact 
knowing the atom number, the molecular weight and polydispersity. A better way to 
compare AuNPs toxicity is the gold atom molarity. The most frequently used methods 
to quantify gold molarity are atomic absorption spectroscopy (AAS), inductively 
coupled plasma atomic emission spectrometry (ICP-AES) and inductively coupled 
plasma mass spectrometry (ICP-MS). In addition, neutron activation analysis (NAA) 
can measure even trace amounts of the gold. The disadvantage of NAA is limited 
accessibility. In this study, all the concentrations refer to the molar gold concentration 
determined by AAS. 
 
1.2.3.2 Comparing different toxic compounds 
The unit of dose is critical in comparing the toxicity among different compounds. For 
example, the molecular weight of Au1.4MS used in the experiments is 15419 g/mol 
and the molecular weight of cisplatin, a chemotherapy reagent, is 300 g/mol.  The 
IC50s of Au1.4MS and cisplatin tested under the same condition in HeLa cell lines, 
recorded in molar concentrations, are 46 µM and 28 µM, respectively. On the weight 
basis (mg/L), the toxicity of Au1.4MS (IC50=12.9 mg/L) is similar to cisplatin (IC50=8.4 
mg/L). On the basis of compound molarity however, Au1.4MS (IC50=46 µM Au which 
is equal to 0.84 µM Au1.4MS) is 33 fold more toxic than cisplatin IC50=28 µM). To be 
consistent, I used molarity of gold [Au] throughout. When considering pharmacology 
one should however always convert this to molarity of compound [Au1.4MS]. It is 
therefore suggested that the molecular weight and number of the gold atoms of 
AuNPs should be clarified and described in publications. 
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1.3 Difference between bulk and AuNPs 
1.3.1 Gold is the noblest of all metals  
Gold has an atomic number of 79 and is the metal with the highest Pauling 
electronegativity (2.54). Its outer electron configuration is 4f14 5d10 6s1. This 
molecular structure determines that bulk gold is chemical inert considering the 
degree of filling of the antibonding states on the adsorption and degree of orbital 
overlap with the adsorbate 5. Gold has a quasi-continuous electronic band structure 
and high conductivity. Gold cannot be dissolved in any single acid, is resistant to 
rusting, tarnishing, corroding, decomposing and is considered as biocompatible. 
 
1.3.2 Size dependent properties of AuNPs 
AuNPs possess quantum size effect and are different from their bulk form in many 
respects 6. Many properties of AuNPs present a size dependent pattern. For example 
the melting points of AuNPs increase along with their size 7 and the plasmon 
resonance peak red-shifted when the size of AuNPs increases. Additionally, AuNPs 
are shown to accelerate the conversion from carbon monoxide to carbon dioxide 
even at 200 K 8 and the catalytic activity of AuNPs is also predominantly determined 
by their size 9.  
 
1.3.3 Au1.4MS  
The AuNPs intensively studied here are Au55Ph2PC6H4SO3Na12Cl6  (Au1.4MS) 10. 
The diameter of this cluster including the ligand shell is 2.2 ±0.1 nm and the naked 
cluster is 1.4 nm 11. Au1.4MS consists of 55 gold atoms and 12 triphenylphosphine 
monosulfonate (TPPMS) ligands (atom/ligand=55/12), which has a closed-shell 
structure. Among the 55 gold atoms, thirteen of them are central gold atoms, 24 are 
uncoordinated peripheral gold atoms, 12 are TPPMS bound gold atoms and six are 
chloride bound gold atoms. Au55(PPh3)12Cl6, the precursor of Au1.4MS was shown to 
have discrete electronic energy levels and behaved as single electron-switches at 
room temperature. Au1.4MS is of great interest for nanoparticle research because all 
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its chemical, physical electronic and catalytic properties are well characterized. It 
possesses a full-shell structure and very specific properties, which differs either from 
the original metal or molecule; and one of the most important reasons for Au1.4MS 
as subject of investigation is that the toxicity information for phosphine modified 
AuNPs is missing so far. Most of the previous studies are focused on thiol modified 
or citrate modified AuNPs. 
 
1.4 Potential risk of AuNPs 
A large amount of AuNPs under study are designed for in vivo applications due to the 
high penetrability derived from their size and the versatile surface characteristics by 
coupling of biomolecules, which enables AuNPs to bind to specific target 12-17. 
However, the unexpected sediment of nanoparticles in organs has a potential risk to 
induce organ dysfunction and diseases 18, 19. Nanoparticles can also pass the blood 
brain barrier 20, 21 so that they might alter the cerebrospinal fluid 22. The distribution, 
translocation, accumulation and clearance of nanoparticles in organs are correlated 
with the size and surface characteristics 19, 23-27. A study from Balogh et al. showed 
that, with the same size, the positively charged AuNPs of the same size were 
predominantly excreted through the kidney whereas the negatively and neutrally 
charged AuNPs were captured in spleen and liver 28. High amounts of AuNPs 
remaining in the circulation could be taken up by circulating phagocytes 29 and might 
induce inflammation. Furthermore, the nanoparticles could also induce hemorrhage 
due to the unspecific binding of nanoparticles to coagulation factors 30. In addition, 
the cytotoxicity of TPPMS modified AuNPs is known to depend on the size 31. AuNPs 
with a size less than 2 nm are 100 fold more toxic than 15 nm AuNPs. 
 
1.5 Apoptosis and necrosis 
One major concern of nanoparticles safety is cytotoxicity. Cytotoxicity, meaning cell 
poisoning, can result in cell death. Cell death occurs either as apoptosis or necrosis. 
Apoptosis and necrosis are two distinct forms of cell death. Apoptosis refers to the 
programmed cell death that keeps the intracellular content of the dying cell 
sequestered and is energy-dependent. It occurs under both physiological and 
pathological conditions. For example, apoptosis is an effective mechanism to control 
the amounts of different cell populations during development 32, 33 and it is also 
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related with aging 34, 35. Apoptosis is also an efficient defense mechanism of the body 
to survey and kill tumor cells. The defect of this mechanism leads directly to cancer 
36-38. Almost all chemotherapeutic medications kill tumor cells by activating the 
apoptosis process 39. Apoptosis can also be induced by virus infection 40. 
Externalization of phosphatidylserine 41, cell shrinking 42, contact loss with adjacent 
cells and the extracellular matrix, nucleus condensation 43 and fragmentation 44, 
plasma membrane blebbing and formation of apoptotic bodies are the typical 
hallmarks of apoptotic cells 45. In the late stage of apoptosis, in the absence of 
phagocytosis, the plasma membrane and intracellular organelles can break down, 
resulting in the lysis of the fragments, which is called secondary necrosis 46, 47.  
 
Necrosis is usually considered a kind of fast cell death and occurs only under 
pathological conditions. Necrosis is associated with cell swelling, mitochondrial 
damage, rapid depletion of energy, denaturation of proteins, cell lysis and the release 
of intracellular content 48. It is important to distinguish necrosis from apoptosis 
because in necrosis the release of the intracellular content results in a strong 
inflammatory response, inducing further damage of the surrounding tissue. Necrosis 
is often stimulated by exogenous stimuli such as chemical injury, heat shock, hypoxia 
and ischemia. The apoptotic and necrotic cells are also cleaned up through distinct 
mechanism 49. Macrophages engulf apoptotic cells by formation of tight fitting 
phagosomes (zipper-like mechanism) whereas necrotic cells are taken up by 
macrophage through macropinocytosis. Most noxious agents can induce both 
apoptosis and necrosis, depending on the applied dose and duration. For example, a 
low amount of tobacco smoke induced apoptosis whereas a high amount induces 
necrosis 50. 
 
1.5.1 Caspases 
Caspases are a family of cysteine proteases and are normally activated in apoptosis. 
They exist within the cells as inactive form (procaspase). Caspases are regulated at 
the post-translational level that facilitates a rapid response to a certain stimulus. 
Following the stimulus, the prodomain is removed and the active caspase monomers 
cluster into a heteromer that forms the active enzyme. The members of caspase 
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family are classified into two groups: the initiator caspases including caspase -2,-8, -
9, -10 and effector caspases including caspase -3, -6, -7. The effector caspases are 
commonly activated by initiator caspases. The activation of initiator caspases relies 
on the formation of a multi-component which is exemplified by the activation of 
caspase-9 by the so-called apoptosome complex consisting of cytochrome c and the 
apoptotic protease activating factor-1 (APAF1) 51. Except for caspase-1, which is 
firstly identified as an inflammation responser 52, caspases act on the downstream 
substrate and propagate apoptosis 53, 54. Caspases can be activated by both intrinsic 
stimuli as the induction by chemotherapeutic agents which activate the oncogene or 
UV radiation and extrinsic stimuli as the binding of Fas-ligand 55, 56, or TRAIL 57. 
Caspase 3 is the effector caspase mostly activated in apoptosis. Measuring the 
activity of caspase 3 is thus one of the prevalently applied methods to identify 
apoptosis. The activity of caspases can be inhibited by Z-VAD-fmk, which irreversibly 
binds to the catalytic site of caspase and thus inhibits an induction of apoptosis 58, 59. 
 
1.5.2 Staurosporine  
Staurosporine is an ATP-competitive kinase inhibitor 60 due to its stronger affinity to 
the ATP-binding site on the kinase. It is commonly used to induce apoptosis although 
its exact mechanism is not clear. However, some studies indicated that caspase 3 
was activated, which initiated the apoptosis in the presence of staurosporine 61-63.  
 
1.5.3 DNA condensation and fragmentation  
DNA condensation and fragmentation appear commonly in apoptotic cells 42, 64-66. In 
apoptosis, the active caspase 3 specifically binds and cleaves poly ADP-ribose 
polymerase (PARP) to prevent the reparation of damaged DNA. The active caspase 
also applies its effect on the nuclear lamina, the intranuclear proteins that maintain 
the shape of the nucleus and mediate interactions between the chromatin and the 
nuclear membrane. The degradation of the lamina results in chromatin condensation. 
Another important factor is CAD (caspase-activated DNAse), which normally exists 
as an inactive complex together with an inhibitor of CAD (ICAD). The activated 
caspase 3 cleaves ICAD from the inhibitory complex and releases CAD to cut the 
chromosomes into 180 base pair fragments 67. Compared to the condensed and 
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fragmented nuclear fragments that appear in apoptotic cells, swollen nuclei are 
commonly found in necrotic cells.  
 
1.5.4 Cell cycle and DNA content  
The cell cycle is the process by which the genetic material is replicated and 
distributed to daughter cells. The whole procedure consists of four distinct phases 
(G1 phase, S phase, G2 phase and mitosis) and two checkpoints (G1 and G2 
checkpoints). Most of the cellular components except for chromosomes are 
synthesized in the G1 phase 68. In the ensuing S phase, the amount of DNA is 
duplicated. After DNA replication, the cells enter the G2 phase. Most of the enzymes 
that are necessary for the replication especially cellular skeleton proteins like 
microtubules are synthesized in this phase. When all requirements are achieved, the 
cell enters mitosis and one cell divides into two daughter cells in this phase. To 
complete this cycle, cells also pass through two checkpoints that assure that there is 
no DNA damage transmitted to offspring cells. The first checkpoint is located at the 
end of the G1 phase, and thus is named the G1 checkpoint. At the G1 checkpoint, 
DNA damage information, if present, is passed on to ataxia telangiectasia mutated 
(ATM) 69, 70. ATM activates the checkpoint kinase (2ChK2) downstream, which in turn 
phosphorylates the S20 residue of tumor protein 53 (p53). The phosphorylation of 
p53 blocks the interaction between p53 and murine double minute (MDM2) so that 
the level of free p53 increases. The p53 activation leads to an increase of p21. The 
activated p21 suppresses the Cyclin E/ Cyclin-dependent kinase 2 (Cdk2 kinase 
activity) thereby resulting in G1 arrest. The G2 checkpoint is located at the end of the 
G2 phase. To pass the G2 checkpoint, cell division cycle 25C (Cdc25C) needs to 
remove the T14 and Y15 inhibitory phosphorylation of Cdc2, so that Cyclin B1 is 
released from the Cdc2/Cyclin B1 complex. In response to DNA damage, 
phosphorylated Cdc25C binds to 14-3-3 proteins and this complex sequesters the 
Cdc25C in the cytoplasm and prevents the activation of Cdc2 71-73. In parallel to the 
detection and the arrest of cell proliferation, most of the DNA repair pathways are 
activated at these two points. 
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Propidium iodide (PI) based DNA content measurement is commonly used to 
analyze the cellular ploidy and cell membrane permeability, cell cycle and 
proliferation 74, 75. PI is a fluorescent molecule that binds to DNA in a stoichiometric 
manner. After excitation with a wavelength of 488 nm PI emits a red fluorescence 
that can be detected with a 562-588 nm band pass filter. The amount of the 
fluorescent intensity is directly related to the amount of DNA. Cells in the G1 and M 
phases have half of the amount of DNA compared to those in the S, G2 phases 
(Figure 2). Thus, cells in G1 phase have a weaker fluorescence intensity compared 
to those in G2 phase 76, 77.  
 
Figure 2 Schematic diagram depicting the DNA content in different proliferation phases. 
Cells at G1 phase have 2N DNA content. DNA duplicates during S phase and cells have 4N DNA 
content at the end of S phase and G2 phase. In mitosis (M) phase, one cell divides into two daughter 
cells, each with 2N DNA content.  
 
1.6 Cellular redox balance  
1.6.1 Reactive oxygen species and oxidative stress 
Cells utilize oxygen through electron transport chains to produce energy in the form 
of adenosine triphosphate (ATP). Oxygen acts as the terminal electron acceptor 
within the electron transport chain and is reduced to water. In some cases, the leaky 
electrons combine with oxygen and form a free radical or hydrogen peroxide, which 
are called reactive oxygen species (ROS). In addition to the internal production of 
ROS, exposure of cells to UV or heat can also lead to the excessive production of 
ROS. Reactive oxygen species play a pivotal role in controlling cellular reactions. 
The positive aspects of ROS are that it is involved in the efficient mechanism 
protecting the cells against the invasion of pathogens and it is also an important 
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factor to trigger cellular proliferation. On the other hand, the accumulation of these 
deleterious products, beyond the ability of scavenging system to remove them, may 
induce oxidative stress. A low level of oxidative stress can be counteracted by the 
response of the antioxidant response element 78, 79. A moderate level of ROS can 
initiate inflammatory pathways. The ROS is known to be able to activate the 
transcription factor nuclear factor-kB (NF-kB) by releasing it from its inhibitor protein, 
Ik-B, in the cytoplasm. The dissociated NF-kB translocates to the nucleus and alters 
the gene expression pattern 80. ROS have also effect on the activator protein-1 (AP-
1) and mitogen-activated protein kinase (MAPK) 81, 82. An excessive production of 
ROS can damage DNA and lead to cell death 82, 83. Many diseases are to date 
related with the production of excessive ROS including cardiovascular disease, 
cancer, Alzheimer's disease, and Parkinson's disease 84-87. To prevent ROS induced 
cellular damage, the organism has developed a series of defense mechanisms 
including superoxide dismutase (SOD), catalase, glutathione peroxidase (GSHPx), 
glutathione reductase and glutathione.  
 
1.6.2 Glutathione 
Glutathione is made up of L-cysteine, L-glutamic acid and glycine. It is synthesized in 
the cytosol and is transported to other cellular components including the 
mitochondria. Its physiological intracellular level in mammalian cells is in the 
millimolar range (0,5-10mM) 88. Glutathione exists in both the reduced (GSH) and the 
oxidized (GSSG) form. In healthy cells, glutathione is found mainly in its reduced 
form and the GSH/GSSG ratio is 10:1. This ratio can be reversed under oxidative 
stress condition. Glutathione is the most important intracellar low-molecular-weight 
thiol. It is important for protein synthesis, protein degradation, activation and 
inactivation of enzymes, DNA synthesis, and reduction of cystines by involvement in 
the thiol-disulfide exchange. It is found to play a critical role in neutralizing 
intracellular hydrogen peroxide and organic peroxides in the presence of glutathione 
peroxidase; maintaining the intracellular reduce environment 68 (the intracellular 
environment is usually kept at a more reduced status than the extracellular 
environment); manipulating the thiol-disulfide conversions 89; detoxifying foreign 
compounds by forming the conjugation under the catalysis of GSH S-transferases 89-
Introduction 
 
 
 
11 
92; functioning as coenzyme in the glyoxalase reaction 93 and keeping the reduced 
form of thiol groups in many proteins before they fold and form the correct disulfide 
bonds. N-acetylcysteine (NAC) is an effective glutathione substitute attributed from 
its thiol end group and is commonly used as antioxidant to protect the organism from 
oxidative stress 95.  
 
Figure 3 Chemical structures of reduced and oxidized glutathione and NAC. 
 (A) reduced glutathione; (B) oxidized glutathione; (C) N-acetylcysteine 
 
1.7 Gene expression microarray 
A gene expression microarray is a well-established method to measure the changes 
in gene expression at a broad scale. It is made up of a chip with thousands of well-
defined microscopic spots (probes) to which cRNA (sample) binds. Each spot 
represents a specific oligonucleotide sequence. Sample mRNAs are firstly isolated 
from cells or tissues and are reverse transcribed into double stranded cDNA. The 
cDNA is in vitro transcribed into cRNAs in the presence of biotinylated 
ribonucleotides. After fragmentation, biotin labeled cRNA is hybridized to the chip. 
The probes on the chip bind their complementary sample sequences through base 
pair coupling. Arrays are stained with phycoerythrin-conjugated streptavidin. The 
intensity of the fluorescent signal depends upon the amount of target sample binding 
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to the probes. By measuring the fluorescent intensity and pattern, the gene 
expression level can be determined. 
 
1.8 Different models to screen the toxicity of AuNPs 
1.8.1 Cell based toxicity screening test 
The high proliferation rate of cell lines, simple procedures, which can be automated, 
and low costs, make cell-based screening tests popular. Cell experiments have a 
short experimental period and the applied concentration of testing materials can be 
precisely defined. Cell culture tests are suitable to study basic mechanisms including 
endocytosis, death pathways and the interactions between AuNPs and subcellular 
components. The disadvantages of cell culture are that the genome of commonly 
used tumor cell lines and the proliferation pattern are not comparable with normal 
healthy cells. In addition, metabolism, exposure routes and organ specific toxicity of 
intact animals, all of which critically determine outcome, cannot be studies in cell 
culture. 
 
1.8.2 Zebrafish model to test the influence of AuNPs on development 
The zebrafish (Danio rerio) is a popular vertebrate model. Small size, easy 
maintenance, transparency of embryos and the requirement of low amounts of 
testing compounds enable the zebrafish to be used as high throughput toxicity 
screening model. Large amounts of zebrafish embryos can be acquired easily and 
the major important organs are fully developed within 7 days. The transparency of 
their larvae permits the on-line visualization of the internal organs including 
heartbeat, liver development, and angiogenesis. Zebrafish have 85% genetic 
homology with the human genome. In addition, the zebrafish electrocardiogram 
(ECG) shows a pattern that is very similar to the human ECG. Thus the zebrafish 
model is intensively used in cardiotoxicity studies. Many reports have proven the 
good correlation between zebrafish and human in reaction to cardiotoxic compounds. 
For example, quinidine and terfenadine, two human Ether-à-go-go (hERG) ion 
channel blockers, which induce arrhythmia, bradycardia, and abnormal prolongation 
of the time between the start of Q wave and end of P wave (QT interval), which 
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represents the duration of an average ventricular action potential in human, also 
induce atrium-ventricle block and pericardial edema in zebrafish. The zebrafish heart 
forms early in embryonic development. In contrast to the human heart, it consists of 
only two muscular chambers: atrium and ventricle. The atrium collects the blood from 
veins and passes the blood to the ventricle that pumps the blood throughout the 
body.  
 
1.9 hERG channel 
1.9.1 Structure and function of the hERG channel 
Ion channels are protein complexes that are expressed on the cell membrane to 
facilitate the penetration of ions through a bilayer membrane. The hERG channel is 
one of the voltage gated potassium (K+) channels expressed in myocytes and 
nervous tissue. It is well known to mediate the repolarizing (Ikr) current in the cardiac 
action potential. In comparison to other voltage gated potassium channels, the S6 
loop of the hERG protein lacks a proline-X-proline motif that is proposed to insert a 
joint in the inner helix. Therefore, the cavity of the hERG channel is supposed to be 
wider compared to other potassium channels, which is structurally advantageous for 
compound docking 96, 97. In addition, site–directed mutagenesis approaches indicate 
that, compared with other potassium ion channels, the ERG channel has two 
aromatic residues Tyr652 (yellow) and Phe656 (magenta) at S6 domain in the cavity 
of the transmembrane region, which provide high affinity binding sites for various 
compounds (Figure 4). The blockade of the hERG channel can result in a long QT 
syndrome and arrhythmia. Many new chemical compounds are abandoned early in 
the drug development process because they interfere with hERG. Some medications, 
including sertindole, grepafloxacin and terfenadine were withdrawn from the market 
for the same reason (see next page).  
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Figure 4 Homology model of the hERG-channel pore module (S5, S6 and pore helix of two 
subunits) based on the crystal structure of KvAP. Figure taken from reference 97 97. 
The yellow and magenta rings represent Tyr652 and Phe656 rings located on the S6 domain, 
respectively. 
 
1.9.2 Resting potential, action potential, depolarization and repolarization 
The membrane potential of quiescent cells is defined as the resting potential. The 
action potential records the change of cross membrane potential after stimulation. It 
begins with an increase of the membrane potential from the negative resting potential 
to less negative and even to positive values. This process is called depolarization. 
Repolarization is the process in which the membrane potential returns from positive 
to a negative value after depolarization. The action potential is accomplished by 
coordinating the action of different ion channels. The action of hERG channel 
contributes to the repolarization of cardiac action potential. The onset of blockade of 
hERG is reflected on the electrocardiography as the prolongation of QT interval.   
 
1.9.3 hERG: two–gate model  
The two-gate model is applied in this study to explain the action of the hERG 
channel. In this model, the hERG channel consists of two gates 97: the inner 
activation and outer inactivation gates and four conductance states. The four states 
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are closed, open, inactivation and recovery from inactivation. Ions pass through the 
channel and form the tail current only when both gates are opened. If the two gates 
act with the same speed simultaneously no current occur. Actually, the inactivation 
gate reacts to the voltage change much more rapidly than the activation gate 98-100. 
The channel begins with the activation gate closed and inactivation gate open due to 
the negative resting membrane potential. This state is called closed state. The 
activation gate opens slowly during depolarization and the channel convert from 
closed to open status. However, the depolarization also elicits the immediate closure 
of the inactivation gate and the channel goes rapidly to inactivation state, which is a 
non-conductive state. Upon repolarization, the channel recover from inactivation 
state to open state. The rate of the recovery from inactivation exceeds the rate at 
which the channels return to closure, tail peak current is generated in this state. The 
tail current exists until the activation gate is closed thoroughly at the end of 
repolarization. 
 
Figure 5 Schematic diagram depicting the structure and states of hERG channel in response to 
transmembrane voltage. Figure taken from reference 97 97 . 
The channel stayed closed at resting membrane potential and transited to open state followed by a 
quick conversation to inactivation state in response to depolarization. During repolarization, the 
channel recovered rapidly from inactivation to open state and closed at the end of repolarization. 
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2 Materials  
 
2.1 Chemicals 
0.25% Trypsin-EDTA, Gibco, Grand Island, USA  
37% Hydrochloric acid (HCl), Merck, Germany 
5-(and-6)-chloromethyl-2'7'- dichlorodihydrofluorescein diacetate acetyl ester (CM-
H2DCFDA), Invitrogen, Carlsbad, USA 
Agarose, Serva, Heidelberg, Germany 
Apo-ONE®, Promega, Madison, USA  
Ascorbic acid, Sigma-Aldrich, St. Louis, USA 
AurovistTM, Nanoprobes, Yaphank, USA 
CellTraceTMCFSE, Invitrogen, Carlsbad, USA 
Dimethyl sulfoxide (DMSO), Applichem, Darmstadt, Germany 
Dulbecco`s Modified Eagle Medium 1x (DMEM), Gibco, Grand Island, USA 
Ethanol absolute, Applichem, Darmstadt, Germany 
Fetal Bovine Serum (FBS), Gibco, Grand Island, USA 
Hydrogen peroxide 30%, Applichem, Darmstadt, Germany 
Isopropanol, Applichem, Darmstadt, Germany 
JC-1, Invitrogen, Darmstadt, Germany 
L-glutathione reduced (GSH), Sigma-Aldrich, St. Louis, USA 
N-Acetyl-L-cysteine (NAC), Sigma-Aldrich, St. Louis, USA  
Pen Strep Glutamine 100x, Gibco, Grand Island, USA 
Phosphate buffered saline (PBS), Biochrom, Berlin, Germany 
Propidium iodide (PI), Sigma-Aldrich, St. Louis, USA 
Proteinase K, Applichem, Darmstadt, Germany 
Qiagen RNeasy kit, Hilden, Germany 
RNAse, Applichem, Darmstadt, Germany 
Sodium dodecyl sulfate (SDS), Applichem, Darmstadt, Germany 
Staurosporine, Sigma-aldrich, St. Louis, USA 
Thiazolyl blue tetrazolium bromide (MTT), Applichem, Darmstadt, Germany 
Z-VAD-fmk, Bachem, Philadelphia, USA  
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2.2 Materials and instruments 
6-well microtiter plates, TPP, Trasadingen, Switzerland 
75 cm2 tissue culture flask, Greiner bio-one GmbH, Germany 
96-well microtiter plates, TPP, Trasadingen, Switzerland 
Bath chamber, Warner Instruments, Hamden, USA 
Cell counter, Schaerfe System, Reutlingen, Germany 
Cell culture CO2 incubator, Sanyo Biomedical, Wood Dale, USA  
Cell-Quest software, Becton-Dickinson, Franklin Lakes, USA  
Dissecting microscope, Leica, Wetzlar, Germany 
EM400T tansmission electron microscope (TEM), Philips, Eindhoven, Holland 
Facscalibur, Becton Dickinson, Franklin Lakes, USA  
Fluostar, BMGlabtech, Offenburg, Germany 
GeneChip® Human Genome U133A 2.0 array, Affymetrix, Santa Clara, USA 
Inverted microscope, Leica, Wetzlar, Germany 
Lab-Tek II chamber slides, Nunc, Rochester, USA 
Leitz DMIRB microscope, Leica, Wetzlar, Germany 
NanoDrop 1000, Thermoscientific, Wilmington, USA 
OSMOMAT ® 030 cryoscopic osmometer, Gonotec, Berlin, Germany 
Patch clamp amplifier, HEKA ELECTRONIK, Lambrecht/Pfalz, Germany 
PatchMaster, Heka electronik, Lambrecht/Pfalz, Germany 
Petri dish 10 cm, Sarstedt, Nümbrecht-Rommelsdorf, Germany 
pH 330i, WTW, Weilheim, Germany 
Plastic pasture pipette for zebrafish embryo, Roth, Karlsruhe, Germany 
RNA 6000 Nano Assay, Agilent Technologies, Santa Clara, USA 
 
2.3 Cell lines and zebrafish 
HEK293, Cytocentrics, Rostock, Germany 
HEK293-hERG, Cytocentrics, Rostock, Germany 
Zebrafish wild type, descendant of progeny from West Aquarium, Bad Lauterberg, 
Germany 
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2.4 Formulations  
 
Extracellular solution 
140 mM NaCl 
2.5 mM KCl 
2 mM MgCl2 
2 mM CaCl2 
10 mM HEPES 
10 mM glucose 
15 mM sucrose 
pH 7.4±0.1 
osmolality 320±5 mOsmol/kg 
 
 
Intracellular solution 
100 mM K-gluconat 
20 mM KCl 
1 mM CaCl2 
10 mM HEPES 
11 mM EGTA-KOH 
4 mM ATP-Mg2+ 
2 mM GSH 
3 mM phosphocreatine-Na2-H2O 
7 mM sucrose 
pH 7.2±0.1 
osmolality 295±5 mOsm/kg 
 
Egg water is 0.5 fold E2 medium. 
1x E2 medium 
15.0 mM NaCl 
0.5 mM KCl 
1.0 mM MgSO4 
0.15 mM KH2PO4 
0.05 mM Na2HPO4 
1.0 mM CaCl2 
0.7 mM NaHCO3 
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3 Methods 
3.1 Measurement of physical and chemical properties of AuNPs 
3.1.1 AuNPs synthesis and characterization 
Au1.1GSH, Au1.4MS, and, Au15MS were prepared and characterized by Annika 
Leifert at the Institute of Inorganic Chemistry RWTH Aachen. AuPPh3Cl, benzene, 
diethylene glycol dimethyl ether, ethanol, HAuCl4.3H2O, H2SO4, NaBH4, PPh3 and 
sodium citrate dihydrate were purchased from diverse suppliers at the highest purity 
available. All chemicals were used as received, and H2O was obtained from a 
Purelab Plus water purification system. TPPMS was synthesized as described in 
reference 101. Au1.4MS was synthesized as described in reference 11.  
 
Au15MS: Citrate-stabilized gold colloids were synthesized following a published 
protocol 102. For ligand exchange, TPPMS (1 mg per 10 mL of a 0.4 mM solution 
referring to Au) was added to the red gold solution. The mixture was stirred for 5 min 
and kept at 4 oC overnight. To increase the concentration and remove excess ligand, 
the solution was centrifuged to obtain a dark red solution. The UV/Vis spectrum 
showed an absorption maximum at 527 nm.  
 
Au1.1GSH was synthesized according to a published protocol 103. Briefly, HAuCl4 
(100 mg, 0.25 mmol) was dissolved in methanol (50 mL) and GSH (154 mg) was 
added. The solution was cooled to 0oC. A freshly prepared solution (12.5 mL) of 
NaBH4 (0.2 M) was added dropwise over a period of 5 min, during which the color of 
the solution changed from yellow to dark brown. The reaction mixture was stirred for 
30 min and the dark brown precipitate formed was isolated by centrifugation. After 
consecutive washings with a H2O/methanol mixture (1:10, v/v) and pure methanol, 
the solid was dissolved in H2O and filtered through a Millipor filter (pore diameter 20 
nm). The H2O was removed and the product was stored in solid form.  
 
The mean particle size was determined by TEM (FEI Titan S). The sample was 
prepared by placing a diluted solution (5 µL) onto a carbon-coated copper grid.  
Based on elemental analysis, the number of ligands per nanoparticle was 
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determined. For Au1.4MS a Au/TPPMS ratio of 55:12 was obtained, while for 
Au1.1GSH a Au/GSH ratio of 28:11 was achieved. 
 
3.1.2 Osmolality measurement 
The osmolality was measured with OSMOMAT ® 030 cryoscopic osmometer from 
gonatec. The osmometer was calibrated with pure MilliQ water and calibration 300 
standard solution each time before measurement. 50 µL of testing solution was 
pipetted into the disposable plastic measuring vessel followed by pushing the 
measuring vessel onto the measuring vessel holder. Afterwards, the holder was 
lowered into the lower cooling system to automatically measure the sample.  
 
3.1.3 pH measurement 
Cell culture medium containing 10% FBS was warmed up to 37oC. The AuNPs stock 
solution was diluted in the cell culture medium to prepare the final 100 µM working 
solution with the end volume of 10 mL in a 50 mL of Falcon tubes. The instrument for 
the pH measurement (pH 330i from WTW) was calibrated according to the three-
point calibration protocol described in the operating manual. After calibration, the 
electrode was immersed in test solution. The pH appeared on the status display. 
 
3.1.4 Stability of AuNPs in various media 
The stability of AuNPs in various physiological media as shown in Table 2 were 
performed in 96-well microtiter plates. For each test, water-dissolved material (20 µL) 
was added to the medium (80 µL). Materials dissolved in culture media were 
analyzed microscopically after 5 minutes and 48 hours. Stability tests as shown in 
Figure 8 were performed in 1.5 mL eppendorf tubes. For each test, 6 µL of Au15MS 
at stock concentration (10 mM) was added to 194 µL of medium. The macroscopic 
view was taken after 5 and 18 hours.  
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3.2 Cell culture 
3.2.1 Cell line culture 
HeLa human cervix carcinoma cells were cultured in DMEM low glucose medium. 
Medium contained 10% fetal bovine serum, 2.9 mg/ml L-glutamine, 1 mg/ml 
streptomycin and 1000 units/ml penicillin. Cells were cultured at 37 °C in water 
saturated air supplemented with 5% CO2. Culture media were changed every three 
days. Cells were passaged once a week. Cell numbers were estimated using a cell 
counter (Schaerfe cell counting system, Germany). 
 
3.2.2 IC50 measurement with MTT test 
Cytotoxicity of nanoparticles in HeLa cells was determined by the MTT assay. 
Cytotoxicity was measured in the logarithmic phase of cell growth. Cells were 
incubated for 72 hours in 96-well microtiter plates before adding the nanoparticles. 
Fresh medium containing increasing concentrations of nanoparticles was added to 
each well and cells were incubated for another 48 hours. Ten µl PBS containing 5 
mg/ml MTT was dispensed to each well. The plates were incubated for two hours. 
After two-hour incubation, the yellowish water-soluble tetrazolium was converted to a 
water-insoluble purple formazan product within viable breathing cells as a proxy of 
cell number and viability. The water-insoluble formazan was dissolved in a solvent 
mixture (100 mL) consisting of isopropanol (80 mL) with hydrochloric acid (0.04 mM) 
and 3 % sodium dodecyl sulfate (20 mL). Absorption of the samples was measured 
with a spectrophotometer at 595 nm. The amount of formazan produced is directly 
proportional to the number of living cells in the well. All experiments were carried out 
in triplicates. The concentrations of authentic gold samples were re-checked after 
completion of the experiments by atomic absorption spectroscopy. IC50 values were 
calculated using a four parameter logistic equation. Data were plotted as a sigmoidal 
dose-response curve with variable slope using GraphPad PRISM software. IC50 
values were routinely determined in three independent experiments with almost 
identical results.  
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3.3 Viability and death pathway determination 
3.3.1 Fluorogenic caspase activity determination 
HeLa cells were plated in 96-well microtiter plates at initial densities of 2,000 cells in 
100 µL and were incubated for 72 hours before adding nanoparticles. Cells were 
rinsed and 30 µL of medium containing 50 µM Au1.4MS was added. Untreated cells 
served as negative control and cells treated with 0.2 µM staurosporine served as a 
positive control. Apoptosis was measured using the fluorogenic caspase substrate, 
Apo-ONE® homogeneous caspase-3/7 assay (Promega) as described by the 
manufacturer. Briefly, Apo-ONE® stock solution (100-fold working concentration) was 
diluted 50-fold in Apo-One® buffer and 30 µL of this was added to each well and 
incubated at 23°C for 3 hours. 50 µL of the clear supernatant was transferred to a 
black microtiter plate and measured using a Fluorostar Optima plate fluorometer 
(BMG Labtech, Offenburg, Germany) at excitation wavelength 485 nm and emission 
wavelength 520 nm. 
 
3.3.2 Detection of the nuclear fragmentation with the DNA laddering test 
HeLa cells were seeded in T25 plates and grew for 72 hours before addition of 
AuNPs. After 72 hours the cell culture medium was replaced with AuNPs containing 
medium and cells were further kept in the incubator for expected exposure periods. 
After the exposure period, the supernatant was collected into a new 15mL Falcon 
tube. The cells were trypsinized and collected into the corresponding falcon tube, 
which contained the supernatant. Falcon tubes were centrifuged at 1000 g for 5 
minutes. The supernatant was removed with a glass pipette and 300 µL TE/Trition 
buffer was added to lyse the cells. Falcon tubes were left on ice for 10 min. After 10 
minutes, tubes were swirled gently to re-suspend the cells. Cell lysates were 
centrifuged at 13,000 g for 15 min at 4oC. The low molecular weight DNA containing 
supernatant was transfered to a fresh 2 mL microcentrifuge tube. 1.5 µl of 10 mg/ml 
RNaseA was added and samples were incubated for 2 hours at 37oC. 12.5 µl of 10% 
SDS and 2 µL 20 mg/mL proteinase- K were added and samples were incubated for 
another 2 hours at 50oC. After incubation, 0.1 volume of 5 M NaCl and 1 volume of 
ice-cold isopropanol were added into each tube. The samples were incubated on ice 
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for 20 min. The probes were centrifuged at 13,000 g for 14min at 4oC. The 
supernatant was decanted by inverting the tube on a tissue. The dried DNA pellets 
were dissolved in 20 µl TE buffer. The DNA samples were mixed with loading buffer 
by adding 10 fold loading buffer to a final concentration of 1 fold. 20 µL of samples 
and marker were loaded in a 1% agarose gel containing 0.5 mg/mL ethidium 
bromide. Electrophoresis was run in standard Tris/Borate/EDTA (TBE) buffer using a 
Biorad electrophoresis system. An UV transilluminator was applied to visualize 
ethidum bromide stained DNA.  
 
3.3.3 Inhibition of apoptosis with Z-VAD-fmk  
HeLa cells were plated in 96-well microtiter plates at initial densities of 2,000 cells in 
100 µL and were incubated for 72 hours before adding reagents. Cells were left 
untreated or were pre-treated with the caspase inhibitor Z-VAD-fmk for 3 hours 
(BACHEM N1510). A stock solution of 100 mM Z-VAD-fmk in DMSO was prepared 
and kept at -20°C. Working solution was freshly prepared by diluting the stock 
solution in fresh cell culture medium. 
 
3.3.4 Cell cycle and DNA content measurement using flow cytometry 
HeLa cells were plated in 6-well plates and incubated for 72 hours before adding 
nanoparticles. Fresh medium containing nanoparticles (100 µM Au1.4MS) was added 
and cells were incubated for 0, 24 or 32 hours. All cell-material combinations were 
set up in triplicates. After the AuNP incubation, cells were trypsinized and rinsed with 
PBS. Washed cell pellets were fixed in chilled 70% ethanol at 4°C for 60 minutes. 
After fixation, cells were washed with PBS once again and resuspended in 250 µL 
PBS. RNAse (250 µL, 1 mg/mL) and propidium iodide (500 µL, 0.1 mg/mL) were 
added and incubated at room temperature for 15 minutes or overnight at 4°C in the 
dark. Shortly before flow cytometry, cells were washed once with PBS. 20,000 cells 
were analysed using FACSCalibur flow cytometer and CELL-Quest software 
(Becton-Dickinson). 
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3.4 Evaluation the intracellular redox status  
3.4.1 Flow cytometric determination of oxidative stress 
HeLa cells were plated in 6-well plates at initial densities of 40,000 cells in 2 mL and 
were grown for 72 hours. Fresh medium containing nanoparticles (100 µM Au1.4MS, 
1000 µM Au1.1GSH and Au15MS) was added to the cells and incubated for 0, 6, 12, 
18, 24, 48 hours. All cell-material combinations were set up in triplicates. After the 
AuNPs incubation, cells were trypsinized and rinsed with PBS. After rinsing cells 
were suspended in a buffer containing 5-(and-6)-chloromethyl-2'7'-
dichlorodihydrofluorescein diacetate acetyl ester (CM-H2DCFDA) (Molecular 
Probes/Invitrogen). Cells were incubated for 30 minutes at 37°C as described by the 
manufacturer. In brief, 50 µg CM-H2DCFDA powder was dissolved in 100 µL ethanol 
as stock solution and was kept at –20°C. For cell assays the stock solution was 
freshly diluted in PBS to a final working concentration of 2.5 µM. Cells incubated with 
0.3% H2O2 for 30 minutes served as positive control for oxidative stress. 20,000 cells 
were analyzed using FACSCalibur or FACSCanto flow cytometers and CELL-Quest 
software (Becton-Dickinson). 
 
3.4.2 Fluorescent mitochondrial potential staining assay  
HeLa cells were plated in 96-well microtiter plates at initial densities of 2,000 cells in 
100 µL and were incubated for 72 hours before adding nanoparticles. Fresh medium 
containing 100 µM Au1.4MS was added to each well and cells were incubated for an 
additional 0, 1, 6, 12, 18, 24 hours. All cell-material combinations were set up in 
triplicates. A stock solution of JC-1 was prepared in DMSO at 2.5 mg/mL and kept at 
-20oC. The working concentration of JC-1 for HeLa cells was 3 µg/mL. At the end of 
the incubation 100 µL JC-1 stain (Molecular Probes/Invitrogen) at 2-fold working 
concentration was added to each well and incubated for 30 minutes at 37°C. Cells 
were rinsed, mounted in fresh PBS and analyzed by fluorescence microscopy.  
 
3.4.3 Inhibition of Au1.4MS cytotoxicity by reducing agent 
 HeLa cells were plated in 96-well microtiter plates at initial densities of 2,000 cells in 
100 µL and were incubated for 72 hours before adding reagents. Fresh medium 
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containing nanoparticles and/or reducing agents was added to each well and cells 
were incubated for an additional 48 hours.  Final concentrations were NAC, 3 mM, 
GSH, TPPMS and ascorbic acid, 1 mM. Reducing agents were freshly prepared by 
dissolving the powders in H2O to 200 mM and further diluted in fresh cell culture 
medium to working concentration. 
 
3.5 Gene expression analysis 
Gene expression microarray analysis was used to identify differentially expressed 
genes in untreated and AuNPs treated HeLa cells. Total RNA was isolated using the 
Qiagen RNeasy kit. RNA quality was assessed using the RNA 6000 Nano Assay 
(Agilent Bioanalyser) and RNA quantity was estimated using the NanoDrop 1000. 
Total RNA was further processed according the GeneChip® Whole Transcript (WT) 
Sense Target Labeling Assay Manual (Affymetrix, Santa Clara, CA, USA). The 
fragmented labeled sample was hybridized to an Affymetrix GeneChip® Human 
Genome U133A 2.0 Array (Affymetrix). Experimental procedures for the Human 
Genome U133A 2.0 Arrays were performed by the chip facility, IZKF Aachen 
according to the Affymetrix GeneChip® Expression Analysis Technical Manual. 
Briefly, total RNA (each 750 ng) was reverse transcribed into double-stranded cDNA 
using HPLC-purified T7-(dt) 24 primers and the GeneChip® Expression 3-prime 
Amplification one-Cycle Target Labeling and Control Reagents-Kit. Subsequently, the 
purified double stranded cDNA was used as template to synthesize biotinylated 
complementary RNA probes. Hybridization to the array, containing 22,283 probesets 
representing approximately 14,500 well characterized human normalization were 
done with the GCRM algorithm A. MAS 5.0 (Affymetrix) was used for call detection.  
 
3.6 Cell proliferation assay 
HeLa cells were plated in six-well plates and grown for 72h. Cell culture medium was 
removed and fresh medium containing the fluorescent cell-staining dye 
carboxyfluorescein succinimidyl ester (CFSE, Invitrogen) was added. The cells were 
incubated with CFSE for 30 min. Cells were rinsed with ice-cold PBS for 10 min to 
quench background fluorescence. Fresh cell culture medium without or with 100 µM 
Au1.4MS was added and further incubated for 0, 1, 2, 3, or 4 days. A stock solution 
(10 mM) in DMSO was kept at -20oC. The stock solution was freshly diluted in PBS 
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to 5 µM. After trypsinization and washing with PBS, 20 000 resuspended cells were 
analyzed using FACSCalibur and CELL-Quest software (Becton–Dickinson). 
 
3.7 Cell cycle and DNA content measurement using flow cytometry 
HeLa cells were plated in six-well plates and incubated for 72 h before addition of 
nanoparticles. Fresh medium containing nanoparticles (100 µM Au1.4MS) was added 
to the cells, which were incubated for 0, 24, or 32 h. All cell–material combinations 
were set up in triplicates. After the AuNPs incubation, cells were trypsinized and 
rinsed with PBS. The washed cell pellets were fixed in chilled 70% ethanol at 4oC for 
60 min. After fixation, the cells were washed with PBS and resuspended in PBS (250 
mL). RNAse (250 mL, 1 mg/mL) and PI (500 mL, 0.1 mg/mL) were added and 
incubated at room temperature for 15 min or overnight at 4 oC in the dark. Shortly 
before flow cytometry, the cells were washed once with PBS; 20000 cells were 
analyzed using FACSCalibur or FACSCanto flow cytometers and CELL-Quest 
software (Becton–Dickinson). 
 
3.8.Intracellular localization of AuNPs 
3.8.1 Transmission electron microscopy of Au15MS 
HeLa cells were incubated in Lab-Tek II chamber slides until 80% confluence. AuNPs 
were added and cells were incubated at 37oC with 5% CO2. After 1, 6, 12, 24 hours, 
cells were washed twice with cold PBS, fixed in 3% glutaraldehyde for 48 hours and 
post- fixed by in 1% osmium tetraoxide. After fixation specimens were rinsed with 
8.5% sucrose and distilled water, and dehydrated in a graded ethanol series of 30%, 
50%, 70%, 90% ethanol and three times in 100% ethanol, 10 minutes for each. 
Samples were embedded in a mixture of EPON resin in propylene oxide polymerized 
at 37°C. For light microscopy, semi-thin sections of 1 µm were prepared and stained 
with methylene blue. Ultra-thin sections for TEM were prepared using a diamond 
knife, collected on copper grids and contrasted with uranyl acetate and lead citrate. 
Samples were analyzed using an EM400T transmission electron microscope (Philips) 
at the Institute of Pathology, RWTH Aachen University Hospital. 
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3.8.2 TEM protocol applied to localize Au1.4MS 
HeLa cells were incubated in Lab-Tek II chamber slides until 80% confluence. AuNPs 
were added and cells were incubated at 37 oC with 5% CO2. After 1, 6, 12, 24 hours, 
cells were washed twice with cold PBS, fixed in 3% glutaraldehyde for 48 hours. After 
fixation, specimens were rinsed with 8.5% sucrose and distilled water, and 
dehydrated in a graded ethanol series of 30%, 50%, 70%, 90% ethanol and three 
times in 100% ethanol, for 10 minutes each. Samples were embedded in a mixture of 
EPON resin and propylene oxide and polymerized at 37 °C. For light microscopy, 
semi-thin sections of 1 µm were prepared and stained with methylene blue. Ultra-thin 
sections for TEM were prepared using a diamond knife, collected on copper grids. 
Samples were analyzed using an EM400T transmission electron microscope 
(Philips). 
 
3.9 ERG blockade measured by patch clamp 
Patch clamp experiments were performed in Cytocentric AG, Rostock and were 
carried out together with Dr. Olaf Scheel and Annika Leifert.  
3.9.1 Voltage protocol applied to elicit the tail current 
HEK293 cells stably transfected with the gene for the hERG potassium channel were 
used for all patch clamp experience. Shortly before patch clamp experiment, hERG 
transfected HEK293 cells were taken out from liquid nitrogen. After thawing, the cells 
were suspended in extracellular solution (EC) and kept in a cytocentrics cell 
reservoir. To test the dose dependent effect of AuNPs on the hERG ion channel, 
AuNPs at a series of concentrations were diluted in extracellular solution. The 
solution was applied with a tube pump in a slow perfusion model. The cell 
configuration was set up before measurement. After the cell configuration was 
achieved, the cell was lifted up from the cover slip to assure the optimal compound 
perfusion. The cell was superfused in EC for fifteen minutes to stabilize the recording 
condition. The pulse protocol used for hERG activation is shown in Figure 6A and its 
corresponding tail current trace is shown in Figure 6B. The peak tail current occurred 
immediately after the voltage was stepped back to -50 mV and attenuated with 
increasing degree of closure of the inner gate of the channel. The resistance 
between the cell membrane and the patch electrode substrate (seal resistance, 
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Rseal) was proved to achieve gigaseals to assure the reliability of the measurement. 
In addition, the membrane resistance was consistently larger than 500 MΩ and 
access resistance was smaller than 10 MΩ throughout the whole measurement.  
 
Figure 6 Pulse protocol for hERG channel measurement and its corresponding current curve 
trace recorded from a hERG transfected cell. 
(A) Schematic view of the measurement protocol: The mesurement began with stepping the holding 
potential of -80 mV for 200 ms followed by clamping to -50 mV for 200 ms. A pulse was given to clamp 
the holding potential to 40 mV for 2 seconds. For repolarization, the next pulse was given to set the 
potential back to -50 mV for 2 seconds. At the end, the voltage was stepped back to the beginning 
holding potential, -80 mV. (B) Current trace activated within one pulse protocol: No current was 
detected at -80 mV. When the membrane potential was depolarized from – 80 mV to -50, the leak 
current occurred. The potential was further depolarized to 40 mV for 2 seconds to measure the 
steady-state current. In the process of repolarization, the potential was stepped back from 40 mV to -
50 mV for 2 seconds, the peak tail current occurred and it attenuated to zero when the ion channel 
was closed tightly at the end of repolarization. 
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3.9.2 The peak tail current after exposure to AuNPs in time course  
Cells in stable configuration were suspended in different testing solutions. The 
voltage protocol described in 3.9.1 was repeated every 10 seconds. The peak tail 
current occurring at the 2nd second in sequential circles was recorded to monitor the 
change of the peak tail current after exposure to test solutions. 
 
3.10 Zebrafish based toxicity screening test 
3.10.1 Zebrafish raising and breeding 
Zebrafish embryos were kindly provided by professor Henner Hollert, at Department 
of Biology, RWTH Aachen University. Adult Zebrafishes were maintained at 26.5oC 
on a 14h/10h light dark cycle in tank. One day before experiment, a clean glass 
vessel with a metal cover was put into the fish tank. This cover consisted of clean 
plastic grass and a stainless mesh. The holes of the mesh are larger than the 
diameter of the embryos so that the embryos could pass the mesh and precipitated 
on the bottom of the vessel. One hour after lights came next day, the vessel was 
taken out of the tank and the embryos were collected in a plastic mesh sieve. The 
fertilized embryos were selected out under a dissecting microscope. 
 
3.10.2 Mortality measurement of AuNPs treated zebrafish embryos  
This experiment was done in 24-well plates. The bottom of 24-well plate was covered 
with 1.5% agarose one day before using. AuNPs and ligand stock solutions were 
diluted in egg water to prepare a series of working concentrations. 1 mL of test 
solutions was added into each well. Ten fertilized eggs were added into each well 
with a plastic pasteur pipette. Embryos exposed to 1 mL of egg water served as 
nontoxic control. All the embryos were cultured in a 28oC incubator. The morphology 
of embryos was observed at 24, 48 and 72 hpf and the percentage of viable, dead 
and hatched larvae in each well was recorded. A mixture of Au1.4MS and glutathione 
was prepared by mixing 500 µL of Au1.4MS at 2-fold of final test concentration with 
500 µL of glutathione at 1 mM. The mortality was calculated based on three 
independent experiments and each with duplications. 
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3.10.3 Zebrafish heartbeat analysis 
This experiment was done in 96-well plates. The bottom of the 96-well plate was 
covered with 50 µL of 1.5 % agarose one day before the experiment. 100 µL of each 
test solution was added into each well. One embryo was seeded in each well with a 
plastic pasteur pipette. The heartbeat was counted under a DMIRB Leica inverse 
phase microscope. The mean values and standard deviations were calculated based 
on values obtained from the survived embryos in eight replications. 
 
3.10.4 The toxicity of Au1.4MS in zebrafish larvae 
Twenty embryos were cultivated in 10 cm petri dishes containing egg water until 55 
hpf. At 55 hpf, 10 of them were moved to a 96-well plate (one embryo per well), 
where each well contained 200 µL egg water. The other 10 embryos were moved to 
wells containing 200 µL of Au1.4MS at 50 µM. The morphology of embryos was 
continuously observed until day 8 after fertilization. 
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4 Results 
4.1 AuNPs qualification 
The sizes of Au1.4MS, Au1.1GSH and Au15MS were 1.4, 1.1 and 15 nm 
respectively, determined by TEM. The elementary analysis of Au1.4MS showed only 
one peak at 36.55 ppm in 31P-NMR spectrum. Before AuNPs were used in cell 
experiments, the osmolality, pH and stability of AuNPs in each medium were tested. 
 
4.1.1 Osmolality measurement 
High osmolality is an important factor that contributes to toxicity. Therefore, the 
osmolality of all nanoparticles and the ligand was measured prior to the cell 
experiments. The osmolality of cell culture medium was 320 mOsmol/kg, which was 
physiologically isotonic. A fluctuation of 10 mOsmol/kg was considered as acceptable 
for cell culture experiments. In patch clamp studies, the fluctuation of osmolality 
should be less than 5 mOsmol/kg. The osmolality of all particles and the ligand 
TPPMS was plotted against the concentration of the compounds. The concentration 
of the ligand and of all nanoparticles, with the exception of the Aurovist particles, 
used in cells, zebrafish and patch clamp experiments was below 1 mM. As shown in 
Figure 7, the osmolality of all gold compounds at a concentration of 1 mM and of 
TPPMS was below 5 mOsmol/kg. That was much lower than the osmolality of 1 mM 
NaCl and therefore, its effect, in respect of osmolality, can be neglected. Even at 10 
mM, all compound exhibited less than 13 mOsmol/kg osmolality.  
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Figure 7 Plot of osmolality against compound concentrations. 
The black ( ) pink ( ) orange ( ), green  ( ) blue ( ) and purple ( ) lines represent the 
osmolality of Au1.4MS, Aurovist, Au(TPPMS)Cl, Au15MS, NaCl and TPPMS at different 
concentrations, respectively.  
 
4.1.2 Gold nanoparticle pH measurement  
Strong changes of pH in the medium induce cellular stress reaction, cellular protein 
denaturation and, ultimately, cell damage. Thus, the pH of all the compounds was 
measured at 100 µM prior to toxicity experiments. As shown in Table 1, the addition 
of AuNPs at a concentration of 100 µM did not affect the pH of the cell culture 
medium. All pH values ranged from 7.34 to 7.42, which was optimal for cell and 
zebrafish culture. On the basis of the pH measurement, an adverse influence of 
AuNPs derived from pH changes on the cellular growth could be excluded.  
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Table 1 pH of 100 µM AuNPs in cell culture medium.  
 
 
The pH of most of the test compounds was also surveyed by observing the color 
change of cell culture medium throughout the incubation as the cell culture medium 
contained phenol red that turned yellow when the pH was lower than 6.8 and bright 
pink when the pH was larger than 8.2. 
 
4.1.3 Gold nanoparticle stability in media 
The stability of nanoparticles in solution is determined by van der Waals force, 
electrical double layer repulsive force and the nature of the solvent. Nanoparticles for 
medical use should be stable in aqueous solution. However, the increased ionic 
strength of physiological solutions may potentially decrease the stability of AuNPs 
and finally led to aggregation. In this thesis, DMEM, patch clamp extracellular 
solution and E2 zebrafish egg water were used to dissolve the AuNPs. HeLa and 
HEK293 cells were cultivated in medium containing 10% FBS. Thus, the stability of 
all AuNPs in these solutions was tested (Table 2). 
  pH 
DMEM+10%FBS (DF) 7.42 
Au1.2MS in DF 7.37 
Au1.4MS in DF 7.43 
Au1.8MS in DF 7.34 
Au15MS in DF 7.41 
Au1.1GSH in DF 7.41 
Results 
 
 
 
34 
Table 2 The stability of AuNPs in different solutions 
 ddH2O DMEM DMEM+FBS EC EC+FBS E2 
Au0.8MS - - - - - - 
Au1.2MS - - - - - - 
Au1.4MS - - - - - - 
Au1.8MS - - - - - - 
Au1.95MS - - - - - - 
Au2.1MS - - - - - - 
Aurovist - - - - - - 
Au15MS - + - + - + 
Au1.1GSH - -/+ - -/+ - -/+ 
(-) no aggregation appeared within 48 h; (-/+) aggregation observed after more than six hours of 
incubation; (+) aggregation observed directly after addition; TPPMS-stabilized (MS); bidistilled water 
(ddH2O); patch clamp extracellular solution (EC); fetal bovine serum (FBS); zebrafish embryo egg 
water (E2); glutathione (GSH) 
  
All TPPMS modified AuNPs of a size of 0.8 to 2.1 nm and Aurovist particles were 
stable in all media. However, the stability of Au15MS and Au1.1GSH was decreased 
in DMEM and in patch clamp extracellular solution, both of which had high ionic 
strength. The instability of Au15MS and Au1.1GSH in high ionic strength solutions 
could be reversed by the addition of 10% fetal bovine serum (see next page).  
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Figure 8 Macroscopic view of the stability of 300 µM Au15MS under serum and serum free 
conditions after five minutes (A) and 18 hours (B). 
Au15MS at 10 mM was prepared in bidistilled water as stock solution. The stock solution was further 
diluted in (1) bidistilled water, (2) water containing 10% FBS, (3) patch clamp extracellular solution, (4) 
extracellular solution containing 10% FBS, (5) DMEM, and (6) DMEM containing 10% FBS. The 
concentration of Au15MS was 300 µM. 300µM Au15MS was stable in water and water containing 10% 
FBS as shown in A1, A2, B1 and B2. The solution appeared mauve and was homogenous. In EC 
solution, after adding Au15MS, the color of the solution turned immediately to grey as shown in (A3) 
and the precipitation was obvious at the bottom of the tube 18 hours after incubation (B3). Compared 
to A3 and B3, Au15MS was stable in the EC with 10% FBS, the solution appeared mauve (A4, B4) 
and even after 18 hours, no precipitation appeared (B4). Similar to the result observed in EC, Au15MS 
was unstable in DMEM and precipitation was observed after 18 hours of incubation (B5). The addition 
of 10% FBS increased the stability of Au15MS in DMEM and no color change (A6) or precipitation 
occurred at the bottom of the tubes after 18 hours of incubation (B6). 
 
The microscopic views of Au15MS in different media are shown in Figure 9. The 
aggregation appeared directly after Au15MS was added into EC solution and dark 
aggregations occurred. In the presence of 10% FBS, no aggregation was observed in 
the EC solution and the color of the solution was still mauve, which is the normal 
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color of Au15MS in water solution. A similar pattern was observed when Au15MS 
was diluted in DMEM. 
 
Figure 9 Microscopic view of the stability of Au15MS in different solutions. 
 (A) 3 µL 10 mM Au15MS stock solution was added to 97µL extracellular solution. The aggregation 
appeared directly after particle addition and dark aggregations occurred. (B) 3µL 10 mM Au15MS 
stock solution was added to 97 µL EC which contained 10% FBS. There was no aggregation and the 
color of the solution appeared mauve, the color of Au15MS in water. (C) 3 µL of Au15MS at 10 mM 
stock solution were added to 97 µL DMEM medium. The color of the particles turned from mauve to 
modena, a red shift of the transmission spectrum, which indicated particle aggregation. (D) 3µL of 
Au15MS stock solution was added into 97 µL DMEM which contained 10% FBS. In panel D, no 
aggregation or absorption spectrum shift occurred. The color of the solution was still mauve which was 
the normal color of Au15MS in water.  
 
4.2 The ligand dependant cytotoxicity 
Au1.4MS were more than 100-fold more toxic in terms of [Au] than 15 nm particles 
consisting of identical constituents (Au15MS) as we found previously 31. As the next 
step, I evaluated if the ligand chemistry can influence the cytotoxicity of ultrasmall 
AuNPs. To this end, HeLa cervix carcinoma epithelial cells were incubated with 
Au1.4MS and AuNPs of similar size, but with glutathione as ligand, Au1.1GSH. The 
cells were routinely treated in their logarithmic growth phase when they are most 
vulnerable to toxic effects. The toxicity of the different modified AuNPs was quantified 
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by vitality assays using MTT. Figure 10 shows that the IC50 of Au1.1GSH was 3130 
µM (Figure 10 green curve), thus 65-fold higher than the IC50 of Au1.4MS  (48 µM) 
(Figure 10, red curve). The IC50 of the mixture of Au1.4MS and GSH (10 eq) (Figure 
10 yellow curve) was 181 µM and thus almost 4-fold higher than Au1.4MS alone. 
Aurovist, a commercially available AuNPs stabilized with thiol-based endgroups as 
Au1.1GSH, showed also a lower toxicity compared to Au1.4MS. The IC50 of Aurovist 
was 10 mM (Figure 10 black curve).  
 
Figure 10 IC50 of Au1.4MS, Au1.1GSH and Aurovist treated HeLa cells. 
Au1.1GSH shown in the green (IC50 = 3130 µM) has a 65-fold higher IC50 than Au1.4MS shown in 
red (IC50 = 48 µM). The IC50 of Au1.4MS mixed with 10 fold molar excess of GSH is intermediary at 
181 µM. The IC50 of Aurovist was 10345 µM. 
The TPPMS derived toxicity was excluded by measuring the IC50 of TPPMS under 
the same cell culture condition. As shown in Figure 11, no decrease of the viability 
was observed at 100 µM TPPMS and even at much higher TPPMS concentrations as 
used as AuNPs ligand up to 75% of HeLa cells treated with 400 µM TPPMS survived. 
The mole ratio of gold atoms to TPPMS was 55 to 12 in Au1.4MS. In 100 µM of 
Au1.4MS, the amount of TPPMS was 21 µM, which was nontoxic. 
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Figure 11 IC50 of TPPMS treated HeLa cell. 
Cell survival was found to be not affected by the incubation with pure ligand TPPMS for 48 hours over 
a wide concentration range. The IC50 of TPPMS was 1023 µM.  
 
4.3 Cell death pathway determination 
Previous studies showed that TPPMS modified AuNPs with a size ranging from 0.8-2 
nm had high cytotoxicity 31. In addition, annexinV and propidium iodide flow 
cytometric analysis indicated that most of the cells underwent necrosis after 
exposure to Au1.4MS. To confirm this conclusion, DNA laddering electrophoresis, an 
alternative method to detect apoptosis, was performed. 
4.3.1 DNA laddering 
During apoptosis, endonucleases are activated and cleave the internucleosomal 
linker regions producing 180 base pair DNA fragments which appeared as a ladder in 
electrophoresis. HeLa cells treated with 0.2 µM staurosporine were used as positive 
control for apoptosis. Untreated cells showed no fragmentation (Figure 12, lane 2). 
As expected, fragmentation was observed after 6 and 12 hours after staurosporine 
treatment (Figure 12 lane 3 and 4). In contrast, the samples extracted from HeLa 
cells incubated with Au1.4MS showed no fragmentation spanning from 3 to 48 hours 
indicating that cell death was not based on apoptosis. This was consistent with the 
previous observation that Au1.4MS induced cells death predominantly by necrosis.  
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Figure 12 DNA laddering assay of treated HeLa cells. 
 Lane 1: DNA marker; Lane 2: DNA extracts of untreated cells; Lane 3, 4: staurosporine-treated cells 
for 6 and 12 hours respectively; Lane 5-9: Au1.4MS treated cells for 3, 6, 12, 24, 48 hours, 
respectively. 
 
4.3.2 Caspase 3/7 measurement 
In response to particular stimuli, both apoptosis and necrosis can be triggered, but 
one of them dominates. To confirm that the cells after exposure to Au1.4MS 
underwent necrosis instead of apoptosis, caspase 3/7 activity was measured (Figure 
13) using the fluorogenic substrate rhodamine 110 bis-(N-CBZ-L-aspartyl-L-glutamyl-
L-valyl-aspartic acid amide), Z-DEVD-R110. The Caspase 3/7 enzyme cleaved 
carboxy-terminal to the aspartate in the DEVD peptide thus converting the substrate 
into fluorescent rhodamine. Figure 13 showed that staurosporine, an inducer of 
apoptosis, increased intracellular caspase 3/7 activity 6-fold within 6 hours and 
reached peak activity after 12 hours. Thereafter, caspase 3/7 activity declined until 
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the end of the experiment at 48 hours. In contrast, Au1.4MS treated HeLa cells 
showed a comparatively small caspase 3/7 induction of 2-fold, peaking at 18 hours. 
 
Figure 13 Fluorogenic caspase activity determination. 
Caspase 3/7 activity increased about 6.5-fold in staurosporine treated HeLa cells but only 2-fold 
in Au1.4MS treated cells. Caspase 3/7 activity was measured using a fluorogenic protease 
substrate and was presented as relative fluorescence unit (RFU). Treatment with 0.2 µM 
staurosporine for 6-18 hours strongly enhanced caspase 3/7 after incubating the cells for 6 
hours and the activity of caspase 3/7 reached a peak after 12 hours incubation and then 
decreased with further incubation. 50 µM Au1.4MS treated cells had low caspase 3/7 activity 
after cells were incubated with Au1.4MS for 18 and 24 hours. 
To test if the increase in caspase 3/7 activity was necessary and sufficient to trigger 
cell death, the caspase inhibitor Z-VAD-fmk was applied. Apoptosis was 
predominantly caspase-mediated and could be blocked by Z-VAD-fmk whereas 
necrosis cannot. Figure 14 shows that the survival rate of staurosporine-treated HeLa 
cells (white bars) increased from 47% to 90% and 83% respectively after adding 500 
µM and 32 µM Z-VAD-fmk, respectively. In contrast, Z-VAD-fmk treatment did not 
increase cell survival in Au1.4MS treated HeLa cells. This again suggested that 
necrosis not apoptosis occurred in these cells. 
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Figure 14 Reversal of apoptosis by caspase inhibition. 
The caspase inhibitor Z-VAD-fmk inhibited staurosporine-triggered apoptosis, but not Au1.4MS-
induced necrosis. HeLa cells were left untreated as control or were treated with the caspase inhibitor, 
Z-VAD-fmk or with staurosporine (STA) and Au1.4MS as indicated. Z-VAD-fmk inhibited cell death in 
staurosporine-treated cells suggesting apoptosis as the predominant death pathway. When HeLa cells 
were incubated with staurosporine alone, 47% cells survived after 48 hours. The addition of Z-VAD-
fmk increased survival to 90% and 84%, respectively. Z-VAD-fmk did not increase the survival of 
Au1.4MS treated cells suggesting that necrosis was the predominant death pathway in the presence 
of Au1.4MS. 
 
4.4 Oxidative stress  
4.4.1 Intracellular oxidative stress measurement 
The cell permeable stain CM-H2DCFDA, which becomes fluorescent upon oxidation 
by intracellular reactive oxygen species (ROS) was applied to directly demonstrate 
intracellular ROS by flow cytometry. 0.3% H2O2 was used as a positive control. 
Figure 15A showed the flow cytometry analysis of HeLa cells that were left untreated 
and showed no fluorescence (green line) indicating the absence of oxidative stress. 
Upon treatment with 0.3% H2O2, a marked right shift towards stronger fluorescence 
indicated the formation of fluorescein and thus strong ROS generation in H2O2-
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treated HeLa cells (pink line). ROS was likewise detected in HeLa cells treated with 
100 µM Au1.4MS for 12 hours (dark blue line). Intracellular ROS content and thus 
fluorescence intensity continuously increased until the end of the test at 48 hours. In 
contrast, both Au15MS (violet line) and Au1.1GSH (orange line) did not trigger the 
formation of intracellular ROS even at 10-fold higher concentrations and their curves 
were indistinguishable from the untreated control. Consistent with the results 
obtained from MTT measurement, treatment of the cells with TPPMS alone did not 
cause an increase in intracellular fluorescence as shown in Figure 15B. The 
formation of the ROS was reduced by addition of 1 mM glutathione or 1 mM NAC but 
not by ascorbic acid (Figure 15C) (see next page).  
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Figure 15 Flow cytometry determination of oxidative stress. 
 (A) CM-H2DCFDA staining showed that Au1.4MS but not Au15MS and Au1.1GSH induced 
oxidative stress in HeLa cells. The green line (⎯) represents the untreated HeLa cells showing 
no oxidative stress. The pink line (⎯) represents HeLa cells treated with 0.3% H2O2 for 30 
minutes suffering strong oxidative stress as positive control. HeLa cells treated with 100 µM 
Au1.4MS for 6, 12, 18, 24, and 48 hours, respectively (⎯ )(⎯ )(⎯)(⎯ )(⎯) show progressively 
increasing accumulation of intracellular fluorescein and thus oxidative stress. The oxidative 
stress induced by Au1.4MS was obvious after 12 hours (⎯ ) and steadily increased until the end 
of the test at 48 hours. In contrast HeLa cells treated for 48 hours with 1 mM 15 nm Au15MS 
(⎯) or 1 mM Au1.1GSH (⎯) shows no elevated intracellular fluorescein accumulation and thus 
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no oxidative stress even at this 10-fold higher concentration than Au1.4MS. (B) TPPMS alone 
did not induced oxidative stress in HeLa cells after incubation with 100 µM of TPPMS for 48 
hours (⎯) and showed similar values like untreated HeLa cells (⎯). The pink line (⎯ ) 
represents HeLa cells treated with 0.3% H2O2 for 30 minutes. (C) (⎯) represents untreated 
HeLa cells and (⎯ ) represents Au1.4MS 100 µM 32h. The pink line (⎯ ) represents HeLa cells 
treated with 0.3% H2O2 for 30 minutes, (⎯ ) represents HeLa cells treated with a mixture of 100 
µM Au1.4MS and 1 mM glutathione for 32 hours, (⎯) represents  HeLa cells treated with a 
mixture of 100 µM Au1.4MS and 1 mM NAC, (⎯) represents HeLa cells treated with a mixture 
of 100 µM Au1.4MS and 1 mM ascorbic acid. 
 
4.4.2 Evaluating the mitochondrial membrane potential from cells treated with 
Au1.4MS 
Oxidative stress is associated with protein and lipid oxidation ultimately leading to a 
profound alteration in mitochondrial function which is thought to constitute the central 
role of cell death 104. Mitochondrial damage can be monitored based on the 
mitochondrial membrane permeability transition (PT), which results in a sudden 
increase of the permeability of the inner mitochondrial membrane to solutes below 
1500 Da. This leakage can be monitored using the cationic fluorescent dye JC-1 that 
accumulates in mitochondria of healthy cells where it emits red fluorescence. Upon 
PT, the mitochondrial membrane potential (Δψ) increases and the mitochondrial 
membranes become leaky and monomeric JC-1 is released into the cytoplasm and 
emits green fluorescence. Figure 16 showed that untreated HeLa cells stained 
brightly red whereas treatment of the cells with Au1.4MS for 1, 6, 12, 18, and 24 
hours resulted in progressive rounding of the cells and green coloration. This 
observation indicated that PT increased continuously for up to 24 hours in a time 
dependent manner (Figure 16B-F). 
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Figure 16 Fluorescent mitochondrial membrane potential staining. 
JC-1 staining indicates mitochondrial membrane depolarization after incubation with Au1.4MS. 
HeLa cells were incubated with 100 µM Au1.4MS and stained with the fluorescent stain JC-1. 
Red punctate staining indicates aggregation of JC-1 in intact mitochondria. Green staining of 
the cytoplasm indicates mitochondrial membrane permeability transition, PT and depolarization 
with concomitant discharge of JC-1 monomer into the cytoplasm. (A) untreated HeLa cells (B) 1 
hour treatment with 100 µM Au1.4MS. Further incubation for (C) 6 hours, (D) 12 hours, (E) 18 
hours (F) 24 hours shows progressive and continued mitochondrial membrane PT. 
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4.4.3 Abolishing Au1.4MS cytotoxicity by reducing agents 
The results presented above showed that Au1.4MS nanoparticles induced oxidative 
stress, caused mitochondrial membrane permeability transition and triggered cell 
death by necrosis. Next, it was investigated if the oxidative stress was caused by 
ROS emanating from the AuNPs themselves or if ROS production occurred 
secondary to AuNPs endocytosis and interaction with intracellular target molecules 
that triggered an oxidative burst reaction in the cells. To this end, the Au1.4MS 
nanoparticles or the cells were pretreated with the reducing agents N-acetylcysteine 
(NAC), glutathione, TPPMS and ascorbic acid. I studied if a specific treatment could 
abolish the Au1.4MS toxicity. Figure 17 showed the cell survival of untreated HeLa 
cells (Figure 17 columns A), HeLa cells treated with 100 µM Au1.4MS alone 
(columns B) or in combination with other reagents (columns C-G). Treatment with 
Au1.4MS alone killed 96% of cells within 48 hours. Pre-treatment of the cells 
(columns C) with reducing agents NAC, GSH, TPPMS and ascorbic acid resulted in a 
slight increase in cell survival to 7%, 15%, 11% and 6%, respectively. In contrast pre-
treatment and co-incubation of Au1.4MS with NAC, glutathione and TPPMS restored 
cell survival to values between 65% and 93% of the untreated cells (Figure 17, 
columns D-F). Thus treating HeLa cells with reducing agents alone hardly influenced 
cell survival while co-incubation of Au1.4MS with the reducing agents NAC, GSH or 
TPPMS, but not ascorbic acid for the entire duration of the experiment irrespective of 
the sequence of mixing the reagents increased cell survival considerably. The 
additional reducing agents alone did not lead to a significant decrease of cell viability 
(G). 
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Figure 17 NAC, GSH and TPPMS but not ascorbic acid partially inhibited the cytotoxicity of 100 
µM Au1.4MS. 
(A) Untreated cells. (B) Cells treated with Au1.4MS for 48 hours. (C) Cells pretreated with 
reducing agent for 3 hours, washed and post-treated with Au1.4MS for 48 hours. (D) Au1.4MS 
pre-treated with reducing agent for 3 hours, mixture added to cells for 48 hours. (E) Cells pre-
treated with reducing agent for 3 hours, then added Au1.4MS and incubated for 48 hours. (F) 
Reducing agent mixed with Au1.4MS and mixture immediately added to cells and incubated for 
48 hours. (G) Cells incubated with reducing agent for 48 hours. N=3 in all cases.  
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Figure 18 shows microscopic views of cells treated with Au1.4MS demonstrating that 
most of the cells died and lost the mitochondria function after treatment with 100 µM 
Au1.4MS (Figure 18A). In contrast when the cells were treated with a mixture of 
Au1.4MS and glutathione, most of the cells retained normal morphology and 
mitochondria activity (Figure 18B). NAC, GSH, TPPMS and ascorbic acid reduced 
the vital dye MTT into formazan in solution. Careful rinsing of the cells prior to the 
addition of MTT effectively excluded this extracellular reaction, which may produce 
erroneously high survival scores if it goes unnoticed. Thus, routine microscopic 
observations of cells demonstrating that MTT was converted to formazan only in 
mitochondria, not in the cytoplasm or outside the cells is strongly advised in this kind 
of assay. 
 
Figure 18 Viability test for intact mitochondria and respiratory activity. 
 (A) Cells were treated for 48 hours with Au1.4MS, (B) a mixture of Au1.4MS and GSH, (C) 
Au1.1GSH and (D) GSH alone. MTT was added to the cells for 2 hours to measure respiratory 
activity and thus viability as the amount of MTT reduced to formazan. Mitochondria stained dark 
blue due to formazan accumulation. Please note that mixing Au1.4MS greatly reduced the 
toxicity (A, C) and that Au1.1GSH and GSH were nontoxic to begin with. 
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4.5 Gene expression microarray 
The results from the experiments described before have revealed that Au1.4MS was 
cytotoxic because of continuous generation of ROS. Next, it was determined whether 
the oxidative stress would be reflected also on the level of gene expression. To this 
end, genome-wide mRNA expression analysis was performed using cDNA 
microarrays. mRNA was extracted from untreated, 100 µM Au1.4MS and 1000 µM 
Au15MS treated cells after defined incubation periods and reverse transcribed into 
cDNA. The level of GAPDH house keeping gene was independently measured by 
RT-PCR to ensure that equal amounts of cDNA entered the analysis (not shown). 
Figure 19 shows that a group of growth related genes (PTGER4, EDN1, NR4A1, 
C5orf13, NR4A3, EGR3, FOS, EMP1, CALD1, SERPINE1, EGR1, DUSP5, ATF3, 
DUSP2) were differentially up-regulated in both HeLa cells treated with Au1.4MS and 
with Au15MS at one hour after the onset of treatments (s1h_1. s1h_2, b1h_1, b1h_2). 
This reflected an initial growth response triggered by addition of fresh media along 
with the Au1.4MS and Au15MS illustrating a well-known short-term phenomenon of 
cell culture and confirming the validity of the gene chip expression study. A separate 
clustering of the gene expression changed following treatment with the non-toxic 
Au15MS, which confirmed an overlapping, almost identical group of genes (EGR1, 
NR4A1, DUSP5, PPP1R3B, EDN1, FOS, EGR1, EDN1, ADAMTS1, ATF3, PTGER4, 
CYR61) as up-regulated at 1 hour after medium exchange irrespective of toxicity (not 
shown). Following the initial growth response, heat shock and stress-related genes 
were significantly up-regulated after 6 hours and strongly up-regulated after 12 hours 
in Au1.4MS treated, but not in Au15MS or in untreated HeLa cells. This group of 
genes (HSPA1A, DNAJA4, CHAC1, HSPA1A, DDIT3, GEM, LOC387763, PGF, 
HSPA6, SESN2, LOC284561, PPP1R15A, HMOX1, C16orf81, LOC344887, NGF, 
OSGIN1, FOSL1, CXCL2, IL8) suggested that a robust stress response had occurred 
in the Au1.4MS treated cells. Highly elevated expression of heat shock proteins has 
been demonstrated to inhibit apoptosis at several stages including blocking of 
cytochrome C release from mitochondria, preventing the formation of an apoptosome 
and the activation of caspase-3 105 ultimately forcing cells into necrosis instead of 
apoptosis. 
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Figure 19 Hierarchical cluster analysis and heat map representation of differentially regulated 
genes in AuNPs treated HeLa cells. 
All gene chip analyses were performed in duplicates (_1, _2). HeLa cells were left untreated 
(c1, c2) or were treated for 1, 6 and 12 hours with Au1.4MS (s1h-s12h for small AuNPs) or with 
Au15MS (b1h-b12h for big AuNPs). Gene expression levels determined by Affymetrix® gene 
chips were subjected to hierarchical cluster analysis. Upon treatment with Au1.4MS, 35 genes 
were significantly up-regulated compared to Au15MS treated cells and the untreated control. 
Each gene was depicted by a single row of colored boxes. The color of the respective box in 
one row represented the expression value of the gene transcript in one sample compared with 
the median expression level of the gene’s transcript for all samples shown. Blue, transcript 
levels below median; white, transcript levels equal to median; red, transcript levels higher than 
median. 
 
Taken together the gene expression profile in Au1.4MS was fully compatible with an 
oxidative stress response leading to necrosis. In addition, oxidative stress and 
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inflammation related genes including glutathione-S transferase (GST), heme 
oxygenase-1 (HMOX1), oxidative stress induced growth inhibit (OSGIN1) and IL-8 
were also up-regulated. Most of the down-regulated genes are associated with the 
cell cycle including MEF2C, CCNG2, CCNE2, BRIP1, CCNE1, BARD1, CCNJ, 
CDKN2C, FBXO4, CDKN2B (data not shown). In summary this finding suggested 
that continuous ROS generation was indeed the toxicity mechanism causing cell 
damage. Early repair reactions were started, but down-regulation of the cell cycle 
associated genes showed that eventually necrosis ensued, most likely because the 
AuNPs treated cells were unable to repair the sustained multi-target damage. 
 
4.6 Cell cycle and proliferation  
Next, it was analyzed if the oxidative stress toxicity and the changes in gene 
expression caused a specific block in the cell cycle due to interference with e.g. DNA 
replication or if cells simply stopped dividing because they died of continued oxidative 
stress and necrosis. To gain insight into the cell cycle progression in the context of 
Au1.4MS cytotoxicity, the cellular DNA content and mitotic index of HeLa cells was 
measured. Figure 20 shows the result of a typical flow cytometry analysis of the DNA 
content of HeLa cells after staining the DNA with propidium iodide (PI). Untreated 
cells (black line) showed a minor peak of propidium iodide (PI) fluorescence at 1.5 x 
10e3 depicting 4N cellular DNA content (G2 phase, about 20% of cells) and a major 
peak of fluorescence at 8 x 10e2 indicating 2N cellular DNA content (G1 phase, 70% 
of the cells). Cells staining intermediary reside in S phase. When the HeLa cells were 
treated with staurosporine (green line) to trigger apoptosis the relative proportion of 
cells in G2 phase increased to 50% indicating a G2/M block of the cells. Together 
with the sub G1 peak and the low fluorescent peak indicating DNA fragments this 
pattern was typical of apoptosis. Unlike the staurosporine treated cells, Au1.4MS 
treated cells showed no G2/M block, no sub G1 or fragmented DNA peaks, 
suggesting that these cells did not execute the late stages of apoptosis including 
DNA fragmentation, but went straight into necrosis once the mitochondrial damage 
was manifested and PT had occurred. This was further corroborated by the fact that 
caspase activation, which was likewise a late event in apoptosis, but not in necrosis, 
was low in Au1.4MS treated cells and furthermore, that caspase inhibition by Z-VAD-
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fmk enhanced cell viability in staurosporine treated (apoptotic) cells, but not in 
Au1.4MS treated (necrotic) cells. 
 
 
Figure 20 Flow cytometry of DNA content and cell division. 
(A) Cellular DNA was labeled with propidium iodide (PI) and analysed by flow cytometry. Cells 
treated with staurosporine showed a hypodiploid peak in DNA content typical of G2/M arrest 
and apoptosis (arrow head) while untreated cells and cells treated with Au1.4MS showed 
normal DNA content. (B) Cells were labeled with the fluorescent dye, CFSE and further grown 
for 0, 1, 2, 3, and 4 days. Untreated cells (top panel) underwent 4 cell divisions with a 
concomitant decrease in CFSE fluorescence intensity. (C) Cells treated with Au1.4MS divided 
only once, i.e. never entered a fresh cell cycle.  
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4.7 The intracellular localization of gold nanoparticles 
Transmission electron microscopy (TEM) was applied to analyze how the AuNPs 
were taken up by cells and where they are located, if they were internalized, 
distributed in the cytoplasm, entrapped in the endosome (exosome) or transported to 
the nucleus. To answer this question, transmission electron microscopy was 
performed. The typical protocol for biological ultrathin tissue section preparation was 
first followed. Au15MS was identified inside the endosome in the form of agregate as 
shown in Figure 21C in the ultrathin section. No Au15MS was found inside the 
nucleus under high magnification continuous scanning. The subcellular organelles 
were contrasted and outlined after exposure to osmium tetroxide, uranyl acetate and 
lead citrate. In contrast to the clear endosomal localization of Au15MS seen in the 
TEM images, detection of the Au1.4MS was not possible. The contrast agents 
introduced high background staining preventing Au1.4MS detection because of 
comparable size between Au1.4MS and the ions derived from the contrast agent at 
480.000-fold magnification. To reduce background, a modified protocol, which left out 
all steps introducing metal ions, was performed to localize Au1.4MS as shown in 
Figure 21A and the same view in higher magnification Figure 21B. Each single dark 
particle shown in Figure 21B exhibited smooth margin and regular spherical shape. 
The diameter of these particles was 1.4 nm confirming that these particles were the 
Au1.4MS. Unfortunately, the subcellular localization could not be obtained from TEM 
images as presented here by Figure 21A and B, due to the absence of contrast 
agent.(see next page)  
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Figure 21 Intracellular localization of gold nanoparticles using TEM. 
 Au1.4MS and Au15 MS were taken up by HeLa cell after one hour of exposure. (A) HeLa cells were 
incubated in the presence of 1 mM Au1.4MS for one hour. (B) The view of (A) at higher magnification. 
(C) HeLa cells were incubated with 1mM Au15MS for one hour. 
 
4.8 Influence of AuNPs on hERG channel  
 
Most of the AuNPs currently under study were designed for in vivo applications. A 
high percentage of newly invented drugs failed in clinical trials due to their blockade 
on hERG channels. hERG channels played an important role in repolarization of 
cardiac myocytes. The blocking of hERG channels in ventricles caused Torsades de 
Pointes ventricular arrhythmia. Thus, the influence of AuNPs on hERG channel 
functionality was required to be investigated. To study the influence of an agent on 
the function of ion channel, the patch clamp method is the gold standard and was 
used here in cooperation with Dr. Olaf Sheel and Annika Leifert. 
4.8.1 Au1.4MS blocked the hERG channel 
The osmolality of each test solution was measured to exclude any adverse effect 
derived from an osmolality shock. The tail current kinetic curves from the cell 
exposed to EC solution and 65 µM Au1.4MS, respectively, within one pulse protocol 
after 15 minute superfusion were recorded as shown in Figure 22. When the cell are 
kept in extracellular (EC) solution, the tail current erupted and reached 2000 pA soon 
after the repolarization pulse was applied and attenuated to zero when the channel 
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was fully closed at the end of repolarization. In contrast, the peak tail current was 
absent when the cell was suspended in Au1.4MS solution. This suggested that 65 
µM of Au1.4MS fully blocked the hERG channel within 15 minutes. 
 
 
Figure 22 The current trace recorded from a single cell after exposure to EC and 
Au1.4MS within one pulse protocol, respectively. 
Single cells were superfused in EC solution with or without Au1.4MS for 15 minutes and the current 
trace within one pulse protocol at the end of the exposure were recorded. The peak tail current 
occurred when the cell clamping voltage was switched from 40 mV to -50 mV (repolarization). The 
current decreased gradually afterwards with the closure of the channel between time 2 seconds and 
time 4 seconds. Cells superfused in Au1.4MS solution did not show a peak tail current, which 
indicated the full blockade of hERG channel by Au1.4MS. 
 
The influence of Au1.4MS on hERG channel at different concentrations was further 
investigated. A cell in stable configuration was superfused in extracellular solution 
and increasing amounts of Au1.4MS were applied to the cell. The pulse protocol was 
activated every 10 seconds and the peak tail current within each cycle was recorded. 
Within the first 13 minutes, the amplitude of peak tail current was stable at 1.75 nA, 
represented by the first flat segment. The peak current decreased gradually from 
1.75 to 1.6 nA within the next 13 minutes when Au1.4MS at 3.1 µM was applied. It 
further declined from 1.6 to 1.2 nA in the following 20 minutes when Au1.4MS at 6.5 
µM was applied. 16.5 µM of Au1.4MS was applied to the cell after 46 minutes. At this 
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concentration, the amplitude of the tail current decreased rapidly from 1.2 to 0.5 nA 
within 10 minutes. After 61 minutes, the cell was superfused in extracellular solution 
again. The peak current remained stable after this replacement. There was no 
recovery of peak tail current observed after EC superfusion showing that the 
progressive blockade of hERG channel by Au1.4MS was irreversible. The rate of 
current drop positively correlated with the concentration of Au1.4MS applied, as 
indicated by the continuously decreasing slopes of four red lines labeled in the graph. 
 
 
Figure 23 Au1.4MS irreversibly blocked the hERG channel in a concentration dependent 
manner. 
EC was applied to HEK293 cell stably transfected with hERG potassium channel from minute 0 to 13; 
3.1 µM of Au1.4MS was applied from minute 13 to 26; 6.5 µM of Au1.4MS was applied from minute 26 
to 46; 16.25 µM of Au1.4MS was applied from minute 46 to 61; the cell was superfused in EC from 61 
to 76 minutes. The slope of each segment is illustrated with a red tangent and the slope progressively 
decreased with the increase of Au1.4MS concentration. 
  
Figure 22 and Figure 23 demonstrated that Au1.4MS blocked the hERG channels 
progressively and irreversibly. To investigate if ligand chemistry of AuNPs affected 
channel blocking, two other AuNPs, Au1.1GSH, and Aurovist, which exhibited similar 
atom-core diameters as Au1.4MS, were also tested. The modification layers of 
Au1.1GSH and Aurovist were bound to the gold atom core by thiol groups. Previous 
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results had shown that Au1.4MS at 65 µM fully blocked the hERG channel after 15 
minutes of perfusion. For comparison, all the compounds were applied at 300 µM. 
Unlike with Au1.4MS, the peak tail current remained high for 15 minutes even when 
the cells were exposed to 300 µM either Au1.1GSH (Figure 24B) or Aurovist (Figure 
24C). At the same concentration, Au1.4MS completely blocked the ion channels 
within 7.5 minutes (Figure 24A). When 300 µM Au1.4MS was pre-incubated with 455 
µM glutathione at 37oC prior to the measurement, the mixture induced a rapid 20% 
drop of the current amplitude directly after application, but no further drop of the 
current was observed (Figure 24D). The 20% rapid drop was reversed after rinsing 
the cells with extracellular solution. Following these observations, the effect of 
glutathione at 455 µM alone was studied. The cell with optimal configuration was 
superfused in EC solution for 10 minutes followed with the application of glutathione. 
Figure 24E shows that the 20% drop of the peak current occurred directly after the 
solution replacement but no further current decrease appeared in the 20 minutes of 
perfusion. After 30 minutes, the flow was replaced with Au1.4MS at 300 µM. Under 
this condition, the peak tail current (Figure 24E) decreased much slower than without 
pretreatment with glutathione (Figure 24A). The hERG blockade from Au1.4MS was 
not likely to be merely a spatial effect considering the absence of blockade in 
Au1.1GSH and Aurovist superfused cells; as an alternative explanation, a ligand-
derived blockade effect was suggested. To this end, TPPMS was applied at 
increasing concentrations to the cells and the peak current was recorded  (Figure 
24F). The segments on top of the panels indicate the beginning of the application of 
each concentration. A cell in stable configuration was superfused in EC solution in 
the first seven minutes. From the eighth minute on, the flow was replaced with 25 µM 
TPPMS. The perfusion lasted up to minute 19. From minute 19 to 30, the cell was 
superfused in 70 µM TPPMS. The peak current kept stable until the end of the 
perfusion interval. TPPMS at 350 µM was applied at time 30 minutes and the peak 
tail current dropped from 1 to 0 nA within 10 minutes (see next page). 
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Figure 24 Influence of different compounds on hERG channels measured in hERG stably 
transfected HEK293 cells. 
(A) A cell was superfused in EC solution for the first 5 minutes followed with the application of 300 µM 
Au1.4MS. The current dropped to zero after 12.5 minutes of superfusion. The effective superfusion 
duration of 300 µM Au1.4MS was 7.5 minutes. (B) The cell was superfused in EC solution for the first 
15 minutes followed with the application of 300 µM Au1.1GSH. The flow was replaced with EC 
solution after 30 minutes.  (C) The cell was superfused in EC solution for the first 8 minutes followed 
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by the application of 300 µM Aurovist to the end. (D) The cell was superfused in EC solution for the 
first 2 minutes followed by the application of a mixture of 300 µM Au1.4MS and 455 µM glutathione. 
The application of the mixture was stopped by replacing it with EC solution at time 20 minutes. (E) The 
cell was superfused in EC solution for the first 10 minutes followed by replacement of the solution with 
EC containing 455 µM glutathione. The flow was replaced with EC containing 300 µM Au1.4MS 
solution at time 31 minutes. (F) The cell was superfused in EC solution for the first 7 minutes followed 
by the application of TPPMS with increasing concentrations, 25 µM, 70µM and 350 µM, respectively. 
At time 40 minutes the flow was replaced with EC.  
 
4.8.2 Serum protects hERG transfected HEK293 cells from hERG blockade by 
Au1.4MS 
To study the influence of nanoparticle size on the blocking efficiency of AuNPs, the 
effect of Au15MS at 300 µM on the hERG channel was investigated. However, as 
shown in Figure 9 and Table 2, Au15MS alone was not stable in EC solution and 
aggregated quickly within minutes. To circumvent this problem, 10% FBS was added 
into the EC solution to stabilize Au15MS. For comparison, the Au1.4MS 
measurements were repeated in the presence of FBS. Interestingly, in the presence 
of FBS, neither Au15MS nor Au1.4MS, at 300 µM, which fully blocked the channel 
when administrated serum-free, led to blockade of the hERG channel. These results 
were similar to the curve observed after glutathione application as shown previously 
in Figure 24D. In Figure 25A, EC containing 10% FBS was applied. The peak current 
decreased from 2.2 nA to 1.7 nA within two minutes. At time five minutes, the cells 
were superfused with fresh EC solution containing 10% FBS and 300 µM Au1.4MS. 
No decrease of the peak tail current occurred during the superfusion of the cell with 
this mixture. At time 20 minutes, the solution was replaced with fresh EC solution. 
This replacement restored the peak tail current from 1.7 to 2.2 nA, which was the 
starting peak tail current of this cell. After 30 minutes, the solution was replaced with 
EC solution containing 10% FBS. Consistent with the phenomena that were 
observed in the first 5 minutes, the peak tail current slightly decreased again from 2.2 
to 1.7 nA. As shown in Figure 25B, the cell in stable configuration was exposed to EC 
containing 10% of FBS at the beginning of the measurement. The peak tail current 
decreased from 2.6 to 2 nA within the first two minutes and remained at 2 nA. The 
solution was replaced at time 10 minutes with a mixture of EC solution containing 
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300 µM Au15MS and 10% FBS. This replacement did not change the peak tail 
current and it remained stable at 2.0 nA until the end of the measurement. 
 
 
Figure 25 Both Au1.4MS and Au15MS did not block the hERG channel in the presence of 10% 
FBS. 
(A) The cell was superfused in 300 µM Au1.4MS in the presence of FBS (B) The cell was superfused 
in 300 µM Au15MS in the presence of FBS. Note the initial decrease after the addition of FBS and the 
constantly lower tail current afterwards in all cases compared to the EC solution at the beginning of 
the superfusion. 
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4.9 Toxicity of AuNPs in zebrafish embryos 
Zebrafish have a short reproductive cycles and large number of progeny. They are 
small in size and their embryos and larvae are transparent so that the development 
can be monitored easily. In addition, 20% of the zebrafish genes are known to be 
essential for early development and 99% of these genes are homologous to human 
genes 106. Therefore, the zebrafish model was applied in this study to investigate the 
toxicity of AuNPs in vivo.  
4.9.1 Comparing the toxicity of Au1.4MS with and without glutathione 
The embryonic mortality was measured by exposing zebrafish embryos to a series of 
concentrations of AuNPs and ligand containing solutions. All results were given 
relative to untreated embryos growing in egg water (0.5-fold E2 medium). Each 
embryo was scored alive if development proceeded normally and was scored dead if 
the somites were thoroughly missing and the embryo appeared turbid. The embryo 
was scored as hatched if the larva dechorionated spontaneously. For example, if six 
of ten embryos survived but were not hatched, two of these ten were hatched and the 
other two embryos died, then the percentages of living, dead and hatched embryos 
were 60%, 20% and 20%, respectively. The experiment was considered valid if the 
percentage of the sum of live embryos and hatched fish were above 90% with a 
normal morphology in the wells containing only egg water. The purpose to separate 
the hatched fish from the living embryos was to get an indication of developmental 
retardation in response to treatment. The teratogenicity of the test solutions was 
studied in detail later in this study. 
 
The toxicity of Au1.4MS and a mixture consisting of Au1.4MS and glutathione was 
compared. As shown in Figure 26A, 97% of fish eggs receiving egg water only 
survived on average and 3% died at 24 hours post fertilization (hpf). At 48 hpf, 3% of 
the embryos had died and all other survived including 50% non-hatched alive 
embryos and 47% hatched larvae. All of the 97% survived embryos had hatched at 
72 hpf. At 50 µM Au1.4MS, 95% of the embryos survived at 24 hpf and 5% died. At 
48 hpf, 68% of the embryos hatched and 27% remained non-hatched live embryos 
and 5% died. 95% of the embryos hatched and 5% died at 72 hpf. At 100 µM 
Au1.4MS, 93% of the embryos survived and 7% died at 24 hpf. At 48 hpf, 12% of the 
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embryos hatched, 8% died and 80% stayed as non-hatched embryos and were alive. 
At 72 hpf, 52% of the embryos hatched, 40% stayed as non-hatched live embryos 
and 8% embryos died. At 200 µM Au1.4MS, 85% of the embryos survived and 15% 
died at 24 and 48 hpf. At 72 hpf, 82% of the embryos survived and 2% of the 
embryos hatched. At 400 µM Au1.4MS, 38% of the embryos survived at 24 hpf and 
no embryos survived at 48 and 72 hpf. Thus, like in HeLa cell culture, Au1.4MS was 
toxic and dose-dependently caused death in developing zebrafish embryos. Figure 
26B shows the embryonic survival rate in response to a mixture containing 500 µM 
glutathione and up to 400 µM of Au1.4MS. All the embryos survived at 48 hpf and 
96% embryos hatched at 72 hpf in the presence of glutathione and 50 µM Au1.4MS. 
With a mixture of 500 µM glutathione and 100 µM Au1.4MS, all embryos survived at 
24 hpf. 38% hatched at 48 hpf and the rest stayed as non-hatched live embryos. 97% 
of all embryos hatched at 72 hpf and the rest stayed as non-hatched live embryos. 
Exposed to 500 µM glutathione combined with 200 µM Au1.4MS, 98% of all embryos 
survived at 24 hpf, 67% hatched and the rest stayed as non-hatched live at 48 hpf. At 
72 hpf, 93% hatched and 5% stayed as live embryos. In egg water containing 500 
µM glutathione and 400 µM of Au1.4MS, 88% of the embryos survived at 24 hpf. 
43% stayed live embryos, 12% died and 45% hatched at 48 hpf. At 72 hpf, 78% of 
the total embryos hatched, 12% died and 10% stayed as non-hatched live embryos. 
Thus glutathione like in HeLa cells, alleviated the toxicity of Au1.4MS in zebrafish 
embryos suggesting that oxidative stress caused by the AuNPs was the cause of 
toxicity (see next page). 
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Figure 26 Live-dead-hatched percent of embryos after incubation with Au1.4MS or a mixture of 
Au1.4MS and glutathione at 24, 48 and 72 hours after fertilization. 
(A) Embryonic survival rate at different concentrations of Au1.4MS containing medium. (B) Embryonic 
survival rate in the mixture of Au1.4MS at different concentrations and 500 µM of glutathione. The 
mean values were derived from three independent experiments. In each experiment, duplicate wells 
were set for each condition and each well contained 10 embryos. Data represent mean values ± 
standard deviation.  
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4.9.2 Teratogenesis of Au1.4MS 
The teratogenic effects induced by Au1.4MS in zebrafish were studied further. The 
major study parameters were: the number of somites, the extension of the yolk and 
the prominently sculptured brain at 24 hpf; the length of the larvae if the embryos 
hatched, the development of the notochord, the straightness and shortness of the 
head, the head-trunk angle (HTA), the morphology of the heart and the extent of 
pigmentation at 48 hpf; in addition, the morphology of the heart, the strength of the 
heartbeat, the size of the yolk sac, the morphology of the fins and the openness of 
the mouth were scored at 72 hpf. The head-trunk angle is the angle between two 
imaginary lines: the head line and the trunk line. The head line starts in the center of 
the ear and ends at the center of the eye. The trunk line runs through the notochord 
in the midtrunk region. 
 
At 24 hpf, the embryos that survived in exposure to 0 to 100 µM of Au1.4MS had well 
developed somites, prominently sculptured brain, eyes, ear, normal size of yolk sac, 
and their tails were detached from the yolk sac. There was no obvious malformation 
observed at this stage (Figure 27 A, B, C).  
 
At 48 hpf, the embryos in egg water showed a head-trunk angle (HTA) of 45 °. The 
yolk extension began to taper and the melanophores appeared laterally (Figure 27D). 
The embryos cultivated in 50 µM of Au1.4MS had the same body length and 45 ° 
HTA, but 10% of them exhibited pericardial edema. In addition to the malformation 
occurring after exposure to 50 µM of Au1.4MS, the embryos cultured in 100 µM 
Au1.4MS exhibited less pigmentation (Figure 27F). All embryos died when exposed 
to 400 µM Au1.4MS.  
 
At 72 hpf, the larvae in egg water showed vigorous blood circulation. They were, 
3.6±0.1 mm long and had a head trunk angle of 25 °. Pectoral fin formation, 
iridophores in yolk stripe, looped S-shaped heart and protruding mouth were all 
normal (Figure 27G). The embryos kept in 50 µM Au1.4MS had the same body 
length and head trunk angle as the control, but had pronounced string-like hearts, 
and pericardial edema (Figure 27H) compared to vehicle-treated embryos (Figure 
27G). In addition, the thinning of the yolk was delayed (Figure 28B). In addition to the 
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malformations observed in embryos exposed to 50 µM Au1.4MS, the embryos 
exposed to 100 µM Au1.4MS had 55 ° head trunk angle, further reduced 
pigmentation and a significant decrease in blood flow in video analysis. The larvae 
were 3.1±0.1 mm in length with curved trunks. The ventral-dorsal diameter of the yolk 
sac body was larger than that of control and the yolk sac appeared spherical in 
lateral view. In contrast, the untreated zebrafish embryos had spindle-shaped yolk 
sac of much reduced volume at 72 hpf (Figure 27 G) (see next page). 
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Figure 27 Representative micrographs of Danio rerio embryos that were exposed to egg water 
containing 0 to 100 µM of Au1.4MS at 24, 48 and 72 hpf. 
Danio rerio at 24 hpf (A, B, C), 48 hpf (D, E, F), and 72 hpf (G, H, I, J, K, L) after exposure to egg 
water (A, D, G, J), 50 µM of Au1.4MS (B, E, H, K) and 100 µM of Au1.4MS (C, F, I, L). Embryos 
exhibited somites, tail detachment, normal yolk body size, yolk extension and sculptured brain and 
eyes at 24 hpf (A, B, C). (D) Embryo showing normal morphology and pigmentation in egg water at 48 
hpf. (E) Embryo exposed to 50 µM of Au1.4MS had similar morphology compared to control at 48 hpf. 
(F) Embryo exposed to 100 µM of Au1.4MS had less pigmentation at 48 hpf. (G, J) Embryo in egg 
water had normal pigmentation, HTA, mouth protruding, pectoral fin and looped heart (G lateral, J 
dorsal view) at 72 hpf. (H, K) Embryo exposed to 50 µM of Au1.4MS had string-like heart and 
pericardial edema (H lateral, K dorsal view). Embryos exposed to 100 µM of Au1.4MS had increased 
HTA, less pigmentation, pericardial edema, string-like heart and increased HTA and yolk sac width 
(ventral-trunk orientation; I lateral, L dorsal view).  
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In addition to the malformations presented above, fin malformation was also 
observed in those embryos after exposure to Au1.4MS. The degree of the 
malformation positively correlated with the concentration of Au1.4MS applied. The 
position of the malformation was randomly scattered in dorsal, ventral and caudal fins 
(Figure 28). Fins from untreated zebrafish were smooth and homogenous as shown 
in Figure 28A. In contrast, zebrafish exposed to Au1.4MS had fins with coarse 
surface and convex nodulated structures (Figure 28B). 
 
Figure 28 Representative fin impairment in Danio rerio embryos exposed to 50 µM of Au1.4MS 
at 72 hpf. 
Embryos cultured in (A) egg water or (B) egg water containing 50 µM of Au1.4MS.  
4.9.3 Changes of the heartbeat in response to Au1.4MS  
Zebrafish embryos exposed to Au1.4MS showed pericardial edema and string-like 
heart malformation. In addition heartbeat frequency of embryos exposed to Au1.4MS 
was reduced compared to untreated control embryos (Figure 29). This experiment 
was done in a 96-well plate and the heartbeat was counted without the addition of 
tricaine. Each bar shown in the graph represents the mean heartbeat derived from 
the eight replica measurement of all surviving embryos. Between 22 and 100 hpf, the 
heartbeat of the control embryos steadily increased from 43 to 166 beats per minute 
(bpm). Embryos exposed to 50 or 100 µM of Au1.4MS had a similar heartbeat at 22 
and 32 hpf as the control, but slower heartbeat than control at 48 hpf and at later time 
points. The bradycardia became more pronounced along with the embryonic 
development.  At 48hpf, the heartbeat of the embryos grown in 100 µM Au1.4MS was 
120 bpm, and at 100 hpf the heartbeat was 112 bpm.  In the presence of 50 µM of 
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Au1.4MS, the heartbeat at 48 hpf was 130 bmp compared to 138 bmp in the control 
and 150 to 167 bmp in the control at 76 hpf. The heartbeat decreased to 135 bpm 
compared to 166 bmp in the control at 100 hpf. In addition, a delay of ventricle 
contraction, which was prevalent in the presence of ERG blockade was not observed 
until 55 hpf. At later time points (76 and 100 hpf), the heart contraction frequency was 
further reduced, and in addition the amplitude i.e. the strength of contraction was 
reduced to a weak twitching, which made the analysis of contraction of atrium and 
ventricle difficult.  
 
Figure 29 Graph presenting the toxicity of Au1.4MS in term of heartbeat. 
The mean values of heartbeat at 22 hpf were similar between the groups with 43, 45 and 46 bpm in 
the presence of egg water, 50 and 100 µM of Au1.4MS, respectively. At time 32-100 hpf, both 
frequency of heartbeat and the contraction strength were much reduced, suggesting cardiac damage 
caused by Au1.4MS. The mean heartbeat was derived from replica measurement taken in all surviving 
embryos out of 8 embryos. Number of survived embryos is given above each bar. 
 
4.9.4 Toxicity of Au1.4MS on zebrafish larvae 
Next we asked the question whether Au1.4MS was toxic to zebrafish at each 
developmental stage or if it was more toxic to the embryos at a specific early 
developmental stage. To address this question, zebrafish embryos were cultured in 
egg water, and all embryos were transferred to egg water containing 100 µM 
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Au1.4MS at 55 hpf. The morphology of the embryos at 8 dpf was compared to those 
kept in egg water. Interestingly, 75% of the embryos exposed to Au1.4MS from 55 
hpf on had no pericardial edema. All embryos had powerful heartbeat and abundant 
blood flow. Heartbeat counts without tricaine were impossible to obtain after 100 hpf 
due to the frequent spontaneous movement of the larvae. Heartbeats were recorded 
under slight anesthesia using 0.004% tricaine, but were grossly different from 
heartbeat in conscious fish. Because of the potential side effect of tricaine on 
heartbeat rhythm, heartbeats were not reported in this experiment. In this 
experiment, exposure to 800 µM Au1.4MS killed all the embryos within 5 hours 
corroborating the high acute toxicity of Au1.4MS at this time in development. 
 
 
Figure 30 Danio rerio embryos exposed to 100 µM Au1.4MS at 55 hfp exhibited no pericardial 
edema at 8 dpf. 
(A) Embryo exposed to egg water 0-8 dpf (B) embryo exposed to egg water from 0 to 55 hpf and to 50 
µM of Au1.4MS after 55 hpf.  
 
4.9.5 Glutathione reduced the toxicity of Au1.4MS in zebrafish embryos  
The addition of 500 µM glutathione to egg water containing Au1.4MS strongly 
reduced the toxicity of Au1.4MS. It was analyzed if the presence of glutathione could 
also reduce the malformations in embryos exposed to Au1.4MS. Figure 31 shows the 
morphology of embryos treated with a mixture of GSH and Au1.4MS at different time 
points. In general, developmental retardations, pigmentation loss, pericardial edema, 
impaired blood circulation, string-like heart and impairment of the fins were prevalent 
in the embryos exposed to Au1.4MS. All these malformations were absent or 
reduced in number or extent in the presence of glutathione. All embryos survived 
after exposure to a mixture containing 200 µM Au1.4MS and 500 µM glutathione 
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Embryos had normal body length, pigmentation, HTA, powerful heart contraction, 
and blood circulation. 
 
Figure 31 Representative micrographs of Danio rerio embryos exposed to egg water containing 
500 µM glutathione together with 0 and 200 µM Au1.4MS at 3, 24, 48 and 72 hpf. 
Danio rerio at 3 hpf (A, B, C), 22 hpf (D, E, F), 48 hpf (G, H, I) and 72 hpf (J, K, L) after exposure to 
egg water (A, D, G, J), 500 µM of GSH (B, E, H, K) and the mixture of GSH and 200 µM of Au1.4MS 
(C, F, I, L). Scale bars, 500 µm. 
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The previous results showed that pericardial edema appeared in all embryos 
exposed to Au1.4MS even at the lowest test concentration (50 µM) and 100% of the 
embryos died upon exposure to 400 µM of Au1.4MS at 48 hpf. In the presence of 
glutathione, no embryos exhibited pericardial edema after exposure to up to 200 µM 
of Au1.4MS and 90% of the embryos survived in exposure to 400 µM of Au1.4MS 
and 70% of the embryos survived without pericardial edema (Figure 32). 
 
Figure 32 Comparison of the rate of pericardial edema of Danio rerio embryos that were 
exposed to 0 to 400 µM Au1.4MS with or without 500 µM glutathione at 72 hpf.  
Pericardial edema was absent in embryos cultured in egg water or glutathione. In the absence of 
glutathione, 100% of the embryos developed pericardial edema in exposure to 50 to 200 µM Au1.4MS 
and all the embryos died after exposure to 400 µM Au1.4MS. In contrast, in the presence of 
glutathione, none of the embryos developed pericardial edema after exposure to up to 200 µM 
Au1.4MS and merely 30% of the surviving embryos developed pericardial edema in exposure to 400 
µM Au1.4MS. The pericardial edema percent for each treatment was derived from all surviving 
embryos out of 20 embryos. Number of survived embryos was given above each bar. 
 
4.9.6 Toxicity of ligands on the development of zebrafish embryos 
Au1.4MS was stabilized by TPPMS. In cell culture, TPPMS alone was nontoxic at the 
concentration that was used as ligand. The IC50 of TPPMS tested with HeLa cell 
lines was 1 mM. Both zebrafish and cell culture experiments showed that the 
additional glutathione reduced the toxicity of Au1.4MS. For comparison, the toxicity of 
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TPPMS and glutathione on zebrafish embryonic development was also analyzed. As 
shown in Figure 33, 90% of the embryos survived in medium containing up to 1 mM 
TPPMS. Chemical composition analysis (CHN analysis) confirmed a stochiometry of 
12 molecules of TPPMS per gold cluster of 55 atoms of gold. Thus 100 µM [Au] 
Au1.4MS contained 22 µM TPPMS. This concentration was much lower than the 
concentration for TPPMS causing toxic effects. The mortality induced by glutathione 
was measured and the result is shown in Figure 33 upper panel. At 72 hpf, 52% of 
the total embryos survived treatment with 1000 µM of glutathione and 95% of the 
embryos survived after exposure to 500 µM of glutathione (see next page). 
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Figure 33 Development of Danio rerio embryos after incubation with glutathione and TPPMS at 
24, 48 and 72 hours post fertilization. 
No significant change of the live-dead-hatched ratio was observed in those embryos exposed to up to 
500 µM glutathione and 1 mM TPPMS, respectively along the observation. Upon exposure to 1 mM of 
glutathione, 52% of the embryos survived but most of the survived embryos hatched at 72 hpf. The 
mean values were derived from three independent experiments. In each experiment, duplicate wells 
were set and each well contained 10 embryos. Data represent mean values ± standard deviation. 
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Treatment with TPPMS up to 500 µM did not negatively affect zebrafish development 
in that embryos developed normally compared to the control embryos: all the 
survived embryos hatched at 72 hpf and had a length of 3.6±0.1 mm with normal yolk 
sac morphology. Mouth protrusion, spontaneous movement, heart morphology and 
blood circulation were normal and the heartbeat was regular. Pericardial edema, 
malformations of head, eyes, otoliths, and scoliosis were absent in those embryos at 
72 hpf (see next page). 
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Figure 34 Representative micrographs of Danio rerio embryos that were exposed to egg water 
containing 0 and 500 µM TPPMS at 3, 24, 48 and 72 hpf. 
Danio rerio at 3 hpf (A, B), 22 hpf (C, D), 48 hpf (E, F) and 72 hpf (G, H) after exposure to egg water 
(A, C, E, G) or 500 µM TPPMS (B, D, F, H). Scale bars, 500 µm. 
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Cell experiments have shown that the addition of excess TPPMS to Au1.4MS 
reduced the toxicity of Au1.4MS in HeLa cells. A similar combination was tested in 
zebrafish embryos. Upon exposure to 800 µM Au1.4MS, all the embryos died within 
24 hours and released amnion fluid, which induced aggregation of Au1.4MS (Figure 
35C). In contrast, 90% of the embryos survived in a mixture containing 500 µM 
TPPMS together with 800 µM Au1.4MS at 24 hpf (Figure 35D). In comparison with 
GSH, the additional TPPMS increase the embryonic viability during the first 24 hours, 
but did not reduce the toxicity in the long term. All the embryos exposed to either 800 
µM Au1.4MS or the mixture containing Au1.4MS and TPPMS died at 48 hpf. The 
presence of TPPMS did not decrease pericardial edema as well. All of the embryos 
exposed to either the mixture containing 100 µM Au1.4MS and 500 µM TPPMS or 
100 µM Au1.4MS presented pericardia edema at 72 hpf as shown in Figure 35G and 
H. In comparison with glutathione, which affected long-term protector, TPPMS could 
reduce the acute toxicity of Au1.4MS as short-term protector but was unable to 
irreversibly block the toxicity of Au1.4MS in long term (see next page). 
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Figure 35 Representative micrographs of Danio rerio embryos that were exposed to egg water 
containing Au1.4MS, TPPMS and the mixture of Au1.4MS and TPPMS. 
Danio rerio at 27 hpf (A, B, C, D) and 72 hpf (E, F, G, H) after exposure to egg water (A, E), 500 µM 
TPPMS (B, F), 800 µM Au1.4MS (C), mixture containing of 800 µM Au1.4MS and 500 µM TPPMS (D), 
100 µM Au1.4MS (G) and mixture containing 100 µM Au1.4MS and 500 µM TPPMS (H). 
 
Cytotoxicity experiments had shown that Au1.4MS was much more toxic than thiol 
modified AuNPs (Au1.1GSH and Aurovist) and this toxicity was caused by Au1.4MS 
not TPPMS. The toxicity of Au1.4MS could be reduced by additional glutathione. The 
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results obtained in HeLa cells culture were nearly identical to the results obtained 
with zebrafish as summarized in Figure 36 showing various combination of AuNPs 
and ligands at different concentrations. At 72 hpf, Au1.4MS caused severe 
pericardial edema and string-like heart at 50 µM (Figure 36E) and killed all embryos 
at 400 µM (Figure 36G). Under the same condition, with additional glutathione, the 
toxicity was reduced (Figure 36F, H) and the pericardial edema was absent.  No 
difference was observed between these embryos and the control embryos in egg 
water. Compared to the high toxicity of Au1.4MS, no increased lethality and 
teratogenesis were observed in zebrafish cultured in egg water (Figure 36A) and in 
the presence of up to 3.2 mM Aurovist (Figure 36B) or 500 µM ligand solutions 
(Figure 36C and D) (see next page).  
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Figure 36 Representative micrographs of Danio rerio embryos that were exposed to 0.5 fold E2 
medium containing different testing substance. 
(A) Embryo that was exposed to egg water; (B) Embryo that was exposed to 3,2 mM Aurovist 
containing medium; (C) Embryo that was exposed to 500 µM glutathione containing medium; (D) 
Embryo that was exposed to 500 µM TPPMS containing medium; (E) Embryo that was exposed to 50 
µM Au1.4MS containing medium; (F) Embryo that was exposed to 50 µM Au1.4MS and 500 µM 
glutathione mixture containing medium; (G) Embryo that was exposed to 400 µM Au1.4MS containing 
medium; (H) Embryo that was exposed to 400 µM Au1.4MS and 500 µM glutathione mixture 
containing medium. 
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5 Discussion 
5.1 The influence of byproduct on toxicity 
Gold nanoparticles of 1.4 nm core size with TPPMS modification were cytotoxic. The 
toxicity was inherent to the nanoparticles instead of deriving from contaminations 
from synthesis byproducts and raw materials. The precursor of Au1.4MS was 
[Au55(PPh3)12Cl6], which was synthesized via reducing [Au(PPh3)Cl] to 
[Au55(PPh3)12Cl6] by diborane (B2H6) at room temperature in benzene. Both 
[Au(PPh3)Cl]  and [Au55(PPh3)12Cl6] are only soluble in organic solvents like benzene 
and  dichloromethane. [Au55(PPh3)12Cl6]  was extracted from dichloromethane by 
phase transfer into aqueous solution by Ph2PC6H4SO3Na (TPPMS). Little or no 
Au(PPh3)Cl is transferred into aqueous phase and therefore residual Au(PPh3)Cl is 
an unlikely source of toxicity in the final product  [Au55(TPPMS)12Cl6]. Residual of 
diborane in the Au1.4MS preparation is equally unlikely to be the cause of toxicity 
considering that diborane is a highly volatile gas. Furthermore, the purity of Au1.4MS 
was routinely detected by elementary analysis (CHN analysis) and the existence of 
redundant TPPMS in the free form was excluded by the absence of the peak at -6.26 
ppm in 31P-NMR spectrum. The spectrum showed only one peak at 36.55 ppm. The 
„innocence“ of the TPPMS was further supported by the fact that all the cytotoxicity of 
AuNPs was prominently reduced by the addition of TPPMS. These results showed 
that the toxicity of Au1.4MS was initially derived from gold nanoparticles instead of 
any residual raw materials, byproducts or excessive TPPMS contamination. 
 
5.2. Gold nanoparticles in physiological solution 
Nowadays, scientists focused on generating nanoparticles that were homogenous 
and stably disperse in aqueous solution. One of the considerations was that most of 
the properties particularly possessed by nanoparticles predominantly depended on 
their size 7, 8, 107. The form of existence of nanoparticles relied on the pH, 
temperature, and constitution of the solution. Any change of these conditions may 
lead to a change of the chemical and physical properties of nanoparticles so that they 
might overturn its biological outcome 108. 
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The point that draws attention is which kind of toxicity should be studied: the one that 
nanoparticles exhibit in their exquisitely designed form which exists only under 
certain circumstances, or that present under physiological conditions. This conflict 
stood out distinctly during the investigation of the effect of AuNPs on the hERG 
potassium ion channel in this study. It was shown that Au1.4MS irreversibly blocked 
the hERG channel but this blockade was abolished by fetal bovine serum. With 
respect to a potential influence of AuNPs on human health, it was more reasonable 
to perform the experiment in the presence of serum protein than in saline solution 
considering the existence of a complex composition of proteins, mineral ions, lipids 
and other small compounds in the blood.  
 
In addition to the influence of the high amount of serum on the polydispersity of 
AuNPs, the increased ionic strength in physiological medium was likely to decrease 
the stability of nanoparticles resulting in aggregation. In this study, it was shown that 
with the same ligand (TPPMS), bigger AuNPs exhibited a higher tendency to 
aggregate in Dulbecco`s modified eagle medium (DMEM) and extracellular solutions. 
The addition of serum proteins stabilized to some extent the AuNPs by increasing the 
steric distance between particles, which avoided the aggregation of particles. 
  
5.3 The effect of ligands on nanoparticle toxicity 
In this study TPPMS and glutathione were used to stabilize the gold atom core of 
AuNPs. Interestingly, Au1.4MS was 65-fold more toxic than Au1.1GSH although both 
ligands alone were nontoxic at the concentrations applied to coat the AuNPs. 
Moreover, both ligands reduced the toxicity of Au1.4MS at higher concentrations. 
The similar size but distinct toxicity outcomes indicated that the ligand, to a critical 
extent, played a role in determining the toxicity of AuNPs.  
5.3.1 Interaction between Au1.4MS and GSH 
The decrease of Au1.4MS toxicity in the presence of GSH was considered in the 
context of ligand shell stability. TPPMS, phosphorus binding to the gold core of 
AuNPs was expected to be weaker than GSH sulfur binding and thus TPPMS should 
be stripped off the atom core of Au1.4MS after contact with GSH due to the higher 
enthalpy of the Au-S bond. In accordance with this assumption, after incubating 
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Au1.4MS with GSH, a 31P NMR spectrum of the washed reaction product showed no 
signal at all, whereas an IR spectrum in KBr showed typical signals of GSH, with the 
absence of the S-H stretching vibration at 2526 cm-1. This indicated that the GSH 
was attached covalently to the gold surface via the SH-group 109. Additionally, 
transmission electron micrographs displayed a slightly broadened size distribution 
after ligand exchange, but the particles still had a mean diameter of 1.4 nm (data was 
not shown), indicating that the replacement was only partial and did not alter the 
nanoparticle core size. 
 
5.3.2 Au1.4MS and protein-thiol  
Glutathione is a ubiquitous sulfhydryl-containing molecule in cells that is responsible 
for maintaining the cellular redox status, detoxification, protein kinase function, 
mitochondrial function as well as protein glutathionylation. The condensation reaction 
between glutathione and proteins is called glutathionylation. The proteins that 
experience glutathionylation are mostly abundant in sulfur amino acids (cysteine and 
methionine). Sulfur amino acids (SAA) are recognized as important for maintaining 
the health of an organism. For example, methionine is an important sulfur amino acid 
that maintains the integrity of cell membranes and cysteine plays an important role in 
protein folding. Proteins containing sulfur amino acids are exemplified as coenzyme 
A, metallothionein and transglutaminase. Glutathione is indispensable for maintaining 
sulfur amino acids in their reduced form. A decrease in the intracellular glutathione 
level can lead to misfolding of sulfur amino acids containing proteins and potentially 
induces cell death. Therefore, it was hypothesized that the addition of Au1.4MS 
destroyed the cellular balance via diminishing the glutathione level in parallel with 
attacking protein thiol groups directly.  
 
The fact that N-acetyl-L-cysteine (NAC) and glutathione (GSH), but not ascorbic acid 
were able to reduce toxicity suggests that thiol-containing compounds but not pure 
antioxidants neutralized the interaction of Au1.4MS with biological targets. It 
appeared that glutathione and N-acetyl-L-cysteine had chelated Au1.4MS by forming 
Au-SH bonds and thereby avoided interaction between Au1.4MS with intracellular 
glutathione and SAA protein. Compared with both GSH and NAC, ascorbic acid is a 
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vinylogous carboxylic acid, which has no end group to chelate Au1.4MS. In addition, 
glutathione has a short half-life and exerts its action close to the organelle where it is 
localized. The GSH required to keep the intracellular redox balance is in the 
millimolar range. Therefore, the consistent maintenance of high intracellular thiol 
concentration is required to avoid cell death. This explained why the pretreatment of 
the cells with glutathione or NAC did not reduce the toxicity of Au1.4MS in case the 
toxicity occurred continuously during cell culture. In comparison to GSH and NAC, 
TPPMS passivated Au1.4MS by overlaying on the gold atom core thereby reducing 
the opportunity for Au1.4MS to interact with intracellular glutathione or protein-thiol. 
In summary, the neutralization of continuously formed ROS by antioxidants as well 
as passivation of Au1.4MS by thiol-containing antioxidants were paradigms 
explaining why Au1.4MS was toxic, mixtures of Au1.4MS and reducing ligands were 
less toxic and fully GSH-capped AuNPs were least toxic in HeLa cells. 
 
5.4 The chemical activity of Au1.4MS and oxidative stress 
AuNPs generally have a high surface-to-volume ratio and a specific electronic 
configuration. Phosphine modified AuNPs of 1.4 nm in particular were shown to 
selectively oxidize with dioxygen both in the gas phase 107 and in solution 110. 
Interestingly, thiol-capped gold nanoparticles were inactive in similar free radical 
oxidations and halogen abstractions, most likely due to the stronger ligand-to-metal 
bond of GSH sulfur to the surface of the AuNPs 110. In addition, the catalysis of 
AuNPs strictly depended on the size of the nanoparticles and even with the same 
ligands, all AuNPs with a diameter of 2 nm and above were completely inactive. This 
might also explain why Au1.4MS was much more toxic than all the other AuNPs 
varying in size or ligand assuming that Au1.4MS had the potential to uniquely 
produce reactive oxygen species, and further impair the intracellular redox status 
finally leading to cell death.  
 
5.5 Au1.4MS and mitochondria 
As stated above, Au1.4MS had the potential to alter the intracellular redox condition 
in many respects: either by reducing the intracellular glutathione level, attacking the 
thiol end groups of sulfur amino acids containing proteins or spontaneously 
producing reactive oxygen species. When the intracellular redox balance was 
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disturbed by Au1.4MS, mitochondria immediately responded to the altered oxidized 
status. Mitochondrial permeability transition pores (mPTP) are one of the most 
important structures in the mitochondrial membrane. They remain closed under 
physiological conditions. In the presence of excessive reactive oxygen species 
(ROS), mitochondrial permeability transition pores are opened which leads to a 
depolarization of the membrane potential as the loss of the electrical gradient. The 
opening of the mitochondrial permeability transition pores deteriorates the redox 
condition further by increasing the permeability of the mitochondrial membrane so 
that higher amounts of ROS are produced. In this study, the onset of the permeability 
transition was indicated by the continuous increase of green fluorescence dispersed 
in the cytosol in JC-1 staining and the accumulation of ROS in the CMH2DCFDA test 
in the presence of Au1.4MS.   
 
In addition to the oxidative stress affecting mitochondrial function, nanoparticles with 
a diameter less than 3 nm had been shown to directly interact with the mitochondrial 
permeability transition pores due to their size 111. Mitochondrial permeability transition 
pores contain membrane proteins including the voltage-dependent anion channel 
(VDAC), cyclophilin-D, and adenine nucleotide translocator (ANT). A study of 
Salnikov et al. showed that 3 nm AuNPs penetrated mPTP through the VDAC 
whereas 6 nm AuNPs were excluded by the outer mitochondrial membrane 111. TEM 
was applied in this thesis to localize the Au1.4MS at the cell surface and inside the 
cells. However, at a magnification of 480,000, the contrast agent used to stain the 
cellular structures appeared as electron-dense particles, which made the recognition 
of 1.4 nm AuNPs difficult. Nevertheless, it is well possible that Au1.4MS due to its 
small size and reactivity may enter mitochondria or, alternatively, may form disulfide 
(–S-S-) and thiol-gold-thiol (SH-Au-SH) bonds in the pore structure, which could 
block pores in the open position 112-114. In contrast, free thiol could cause pore 
closure in the absence of Au1.4MS. By measuring the mitochondrial membrane 
potential, Bernardi and coworkers proved that thiol oxidants or crosslinkers including 
menadione, diamide, arsenite and tert-butylhydroperoxide opened mPTP by oxidizing 
vicinal thiol. The dimerized proteins led to an increase in the probability of pore 
opening and caused the loss of the cross mitochondrial proton gradient. The release 
of electrons into the cytosol further destroyed the redox balance and produced 
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excessive ROS. The progressively decreased GSH concentration deteriorated the 
situation by pushing the balance towards the oxidized state. This opening was 
inhibited by adding N-ethylmaleimide or dithiothreitol. 
 
5.6 The influence of Au1.4MS on gene transcription 
Previous studies suggested that the toxicity of Au1.4MS might be due to intercalation 
into DNA 115. This would entail transcriptional blockade as one immediate 
consequence. However, the strongly enhanced expression of 35 genes after 
exposure of HeLa cells to Au1.4MS and the continued expression of GAPDH both 
argued against direct transcriptional inhibition by Au1.4MS. In addition, there were 
two groups of genes that were significantly upregulated by Au1.4MS: the first group 
was represented by inflammation and stress related genes, IL8 and members of the 
heat shock protein family including HSPA-70, DNAJA4-40 HSPH-105, HSPB-22 and 
HSPD-60. The second cluster included oxidative stress related genes including heme 
oxygenase-1 (HMOX1), glutathione-s-transferase (GST) and the oxidative stress 
induced growth inhibitor (OSGIN1). The gene expression profile in Au1.4MS was fully 
compatible with an oxidative stress response leading to necrosis thus corroborating 
that continuous ROS generation was the primary toxicity mechanism causing cell 
damage. 
  
5.7 Au1.4MS and cell death  
As shown previously, Au1.4MS predominately triggered necrosis with a transient 
increase of apoptotic cells 31. Here, to validate this conclusion and to further 
differentiate necrosis from secondary necrosis, several additional methods were 
applied. No distinct surface or biochemical markers of necrotic cell death have been 
identified yet so that necrosis is usually characterized in negative terms by the 
absence of all characteristic features of apoptosis. Phosphatidylserine externalization,  
pro-caspase activation and DNA fragmentation are hallmarks describing the onset, 
process and end of apoptosis, respectively. It was shown that although Au1.4MS 
slightly activated pro-caspase, the inhibition of the caspase activity by Z-VAD-fmk did 
not increase the survival of the cells exposed to Au1.4MS. The absence of DNA 
fragmentation and the subG1 peak in DNA content measurement together with the 
absence of upregulation of apoptosis-related genes including p53, p21, Bcl-2, Bcl-Xl, 
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Bax and Bad consistently proved that cells that were exposed to Au1.4MS died 
through necrosis. 
 
The most important factor determining the selectivity of the death pathway is the 
speed of the decrease of the ATP level and the extent of the mitochondrial damage. 
The occurrence of a slight permeability transition can generally be compensated by 
the cellular antioxidant defense mechanism. The progressive increase of the 
permeability transition leads to the release of cytochrome C into the cytosol, 
activation of procaspases and a series of functional and morphological changes 
including cellular blebbing, nuclear fragmentation and induction of apoptosis. The 
outburst of the permeability transition leads to a quick depletion of ATP, excessive 
production of ROS, a permeabilization of the cell membrane and necrotic cell death 
116. Generally, 15-20% of the normal intracellular ATP level is sufficient to prevent 
necrosis. However, when the damage goes beyond this level, necrosis occurs 
inevitably. All the results presented in this study indicated that necrosis was the 
predominant cell death pathway that was induced by Au1.4MS although the onset of 
the oxidative stress was not clear at this moment. The potential influence of Au1.4MS 
on the intracellular redox balance and the ensuing cellular responses in the presence 
of additional reducing agents are summarized in Figure 37 (see next page). 
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Figure 37 The redox balance change in response to Au1.4MS. Modified figure from 116. 
Au1.4MS induced the mitochondrial permeability transition (MPT) by decreasing the intracellular GSH 
level, attacking the disulfide proteins or spontaneously producing oxidative stress. An intensive 
eruption of mitochondrial permeability transition activated the ATPase, which led to the rapid depletion 
of ATP, plasma membrane failure and necrosis. When the onset of MPT occurred moderately, the 
ATP level was maintained and the caspases were activated followed the release of cytochrome c, 
which led to apoptosis. The MPT could be partially relieved by additional GSH, NAC and TPPMS via 
passivating Au1.4MS and mitigating the oxidative stress. The absence of an effective end group to 
chelate Au1.4MS in ascorbic acid made it insufficient to protect the cells against Au1.4MS effects.  
 
5.8 The interaction between Au1.4MS and the hERG channel 
Gold nanoparticles Au1.4MS clearly influenced the activity of the hERG channel in 
transfected HEK293 cells. However, this interaction probably played only a minor role 
in toxicity of Au1.4MS in HeLa cells, because these cells do not express the channel 
and therefore hERG cannot mediate the primary toxicity. Nevertheless the potential 
interaction of Au1.4MS with the hERG channel is well worth reporting, because 
hERG is a major target for most cardiotoxic drugs. Thus studying a cell line, which 
expresses this channel was used to estimate the potential cardiac risk of AuNPs.  
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5.8.1 Aromatic group in Au1.4MS 
As shown in Figure 38, all the withdrawn drugs have abundant aromatic groups. 
Compounds with high numbers of aromatic rings strongly block the hERG channel 
through the π stacking and hydrophobic interaction of aromatic residues in the hERG 
channel 117. TPPMS had three aromatic rings, which could potentially lead to the tight 
blockade of the hERG channel. Additionally, TPPMS could alter the surface 
character of the Au1.4MS via binding with the serum proteins. Albumin, the serum 
protein, likewise has a high affinity for lipophilic and particularly anionic aromatic 
compounds 118 which are present on the surface of TPPMS modified AuNPs. Thus, 
the high amount of aromatic rings led to a high amount of serum albumin binding 
thus decreased the concentration of free Au1.4MS in the testing solution. In case the 
free Au1.4MS functioned as a channel blocker, the decrease of free Au1.4MS 
alleviates the blocking efficiency, which can be reflected in the less affected tail 
current response curve.  
 
Figure 38 Schematic structures of some drugs withdrawn from the market due to hERG 
blockade. Data derived from www.drugbank.ca 
 
5.8.2 Effect of Au1.4MS on hERG channels 
The slow onset of hERG blocking by Au1.4MS and the irrecoverable tail current after 
a wash-out suggested that Au1.4MS blocked the channel by preferentially binding to 
the inner vestibule 97. As such, it is tempting to speculate that that the blockade 
occurred in an inactivated channel state instead of the open state. An open-state 
channel block was exemplified by R-roscovitine and fluoxetine 119, 120, which was 
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characterized by both rapid onset of the block after exposure to blocker and fast 
recovery after a wash-out. 
 
In what follows, a purely speculative scenario of hERG blockade by Au1.4MS is 
presented. The inactivated state block occurred following a series of procedures. 
Firstly, the compound needs to access the cytosol to be able to dock to the inner 
cavity of hERG channels and was then trapped in the cavity by closure of the 
inactivation gate (outer gate) during depolarization. The inactivation of the channel 
caused twisting of S6 and repositioning of Tyr-652 and Phe-656 and led to high drug 
binding affinity. Thus, the penetration of the compound through the cellular 
membrane was thought to be the prerequisite for the inactivated-state block. TEM 
analyses (Figure 21) suggested that Au1.4MS was located in the cytosol. Studies on 
the cellular uptake of TPPMS might lead to an improved understanding of the role of 
TPPMS in Au1.4MS hERG blockade. In addition, most of the compounds known to 
have high affinity to hERG channels were molecules of 2 nm in size such as 
methanesulfonamides, astemizole and MK-499. The diameter of the atom core of 
Au1.4MS was 1.4 nm and the thickness of TPPMS was 0.8 nm. The diameter of the 
complete Au1.4MS was of 2.2 nm, which structurally fit well to the inner cavity of the 
hERG channel. As stated at the beginning of this part, the aromatic rings were 
expected to increase the blocking risk of the Au1.4MS. Both size and surface 
characteristic of Au1.4MS would thus facilitate channel binding and blockade. 
 
Figure 39 Model depicting the potential interaction between Au1.4MS and hERG channel. 
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The complex size of Au1.4MS was 2.2 nm, which can access to the inner cavity of hERG channel. 
The aromatic end groups on Au1.4MS made it possible to bind with the F656 and Y652 of hERG 
channel and induce blocking. 
 
What cannot be explained in this study was that the blockade already occurred in the 
presence of 3 µM of Au1.4MS. In contrast, the blockade was not observed when 70 
µM of pure TPPMS were applied, although TPPMS was suspected to be an effective 
binding site of Au1.4MS due to its ring-full structure. The difference in hERG blocking 
potency between TPPMS and Au1.4MS may be explained by the small size of 
TPPMS or by a low transport rate of TPPMS through the cell membrane. The 
internalization of TPPMS was probably facilitated by co-transport with gold cores. 
Nevertheless, further experiments are necessary to clarify this point. During whole-
cell recording, the intracellular components come into contact with the intracellular 
solution within the glass capillary pipette after clamping and equilibration with the 
solution over time. Therefore, the intracellular TPPMS level could be increased via 
adding the TPPMS directly into the intracellular solution and equilibrating the solution 
with cytosol. This might help to explain the blocking mechanism of Au1.4MS. In 
addition, an inside-out patch clamp would also be an alternative to minimize the 
effect from the solution transport. 
 
5.8.3 Nanoparticles size and hERG channel blocking efficiency 
Aurovist and Au1.1GSH had similar sizes like Au1.4MS. Yet, both Au1.1GSH and 
Aurovist did not block the hERG channel when the applied concentration was as 
much as 300 µM. These results strongly indicated that the size of the compound 
seemed to be an important but not the only factor that determined the blocking 
potency of nanoparticles. The occurrence of the blockade required both a specific 
size and chemical structure fitting to the channel cavity. Furthermore, regarding the 
nature of the Au1.4MS including weakly binding ligands and the high 
electronegativity of the gold atom, the possibility that the blockade originated from the 
Au1.4MS gold atom core after the TPPMS was stripped off cannot be ruled out.  
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5.8.4 The tail current curves in the presence of either serum or glutathione 
The switch of the perfusion from EC solution to either 10% FBS or glutathione 
containing EC solution elicited a slight shift of the baseline tail current amplitude to a 
constant lower value. The mechanism of this shift was not clear. Nevertheless, serum 
is an important and major component of blood and glutathione was a critical 
intracellular component to keep the cellular redox balance. It was not expected that 
two physiological components would block the hERG channel at the applied 
concentrations, which were both below the physiological concentration. Thus, in this 
study, the matrix based tail current shift was considered to be the effect derived from 
the medium switch and did not affect the validity of the measurement. 
 
5.8.5 The free form of Au1.4MS and its blocking efficiency 
The absence of the tail current decline in the presence of either serum or GSH after 
exposure to Au1.4MS indicated that the evaluation of the amount of active 
components in the testing matrix was especially important. The decrease of the tail 
current in the presence of serum or GSH could be achieved by altering the size and 
(or) configuration of AuNPs. The alteration of the surface characteristics of Au1.4MS, 
by replacing the TPPMS with glutathione, was proved with NMR and IR 
measurements. Generally, in preclinical studies the blocking effects of the 
compounds were measured in saline solution by voltage clamp measurement. In 
consideration of the complex composition of blood, the results here indicated that 
using the routine hERG patch clamp technique for predicting the clinical outcome 
could potentially lead to false positive data 121.  
 
5.9 Influence of AuNPs on zebrafish embryonic development 
5.9.1 Comparison of cell and embryo based experiments  
This study applied two models to test the acute toxicity of various AuNPs. The results 
and conclusions obtained from cell lines and zebrafish embryos were essentially 
identical. Both models indicated that 1.4 nm TPPMS modified AuNPs were much 
more toxic than thiol-capped AuNPs of similar size. All the AuNPs that turned out to 
be innoxious in cell tests, including Au15MS, Au1.1GSH and Aurovist, also caused 
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neither malformations nor an increase of mortality at any concentration in the 
zebrafish embryo tests. The toxicity of Au1.4MS was decreased by adding 
glutathione in cell-based tests. In zebrafish embryonic experiments, both 
malformation and mortality percentage in response to Au1.4MS likewise decreased 
after the addition of glutathione. Additionally, in both models, TPPMS alone was 
nontoxic at the concentration applied as ligand to stabilize Au1.4MS.  
5.9.2 The influence of embryonic chorion on the toxicity of AuNPs 
The effect of particle size should always be taken into account when investigating 
AuNPs toxicity. Here, all the experiments were performed with embryos still inside 
their chorion. The diameter of chorion pores is 500-700 nm 122 and thus much larger 
than the diameter of the AuNPs tested in this study. Most of the malformations and 
growth retardations in the presence of Au1.4MS were observed before hatching. 
Thus, the AuNPs most likely penetrated the chorion freely and the toxicity of 
Au1.4MS on embryos was direct. 
 
5.9.3 Pericardial edema is prevalent in the embryos exposed to Au1.4MS 
All embryos exposed to 50 µM Au1.4MS had pericardial edema at 48-72 hpf and yolk 
sac edema (blue sac) after 96 hpf (data not shown). Zebrafish are freshwater fish 
and thus their intra and extracellular fluid is hyperosmotic compared to the egg water. 
In general, the failure of the osmotic regulation leads to the onset of edema. The 
edema usually starts with pericardial edema ensued with the blue sac syndrome as 
observed in this study. Although the cardiovascular development has been studied in 
much detail by many groups 123, 124, the mechanism of the onset and exact 
mechanism of pericardial edema is still unknown. Various conditions can cause 
pericardial edema. It was reported after dioxin treatment, genetic defect, quantum 
dots as well as silver nanoparticles treatment 125, 126.  In this study, an increased 
resistance in the peripheral vascular, e.g. in the fins (Figure 28) in combination with 
the observed impaired circulation was considered to be one of the reasons that led to 
edema. Indead, further investigations of Au1.4MS on zebrafish kidney, gill and 
epithelial barriers are necessary to understand the mechanism of edema onset. 
 
Discussion 
 
 
 
93 
5.9.4 Correlation between the hERG blockade and zebrafish cardiac 
dysfunction 
The basic physiology of zebrafish and human hearts are homologous and their 
cardiac action potential parameters are very similar. The biophysical properties of 
zebrafish ERG (zERG) channels that were determined using patch clamp also 
indicated that the channel had similar conductivity like the human hERG channel 127 . 
Given the high similarity, zebrafish was considered to be optimal for ERG channel 
testing and related disease studies. A dysfunction of hERG channels was known to 
elicit delayed ventricular repolarization (atrioventricular block), long QT in ECG and 
arrhythmia in human. Under normal condition, the beat ratio of atrium and ventricle 
was shown to be 1:1. Studies showed that most of the medical hERG blockers 
induced both bradycardia 116, 128, 129 and increased atrioventricular beat ratio (2:1, the 
atrial rate was twice the ventricular rate) in a zebrafish model 130. The presence of 
atrioventricular block is believed to be more diagnostic of hERG blockade than is 
bradycardia. In this study heartbeat was observed in embryos exposed to Au1.4MS 
since the beginning of the pharyngula period, but an atrioventricular block was never 
observed in zebrafish exposed to Au1.4MS. Based on these results, the bradycardia 
occurred in those embryos exposed to Au1.4MS directly after fertilization was 
considered as a consequence of Au1.4MS toxicity during development and not a 
cause of ERG channel blockade. The absence of ERG blockade in live zebrafish 
confirms the patch clamp result in that Au1.4MS channel blockade in hERG 
transfected HEK293 cell was abolished, when the experiment was performed in the 
presence of blood serum. I conclude that the potential zERG interaction of Au1.4MS 
was likewise abolished by zebrafish serum protein.  
 
5.9.5 Growth arrest in response to Au1.4MS 
The reduced pigmentation, the increased head trunk angle and the size of the yolk 
sac, delayed yolk extension tapering, decreased larvae length and anemia all 
suggested that growth was arrested in response to Au1.4MS treatment. This growth 
arrest could be the primary influence on the organogenesis of Au1.4MS, but could 
also be related to hypoxia following the cardiac malfunction in the presence of 
Au1.4MS. The decreased blood flow and hypoemia were prominent at 48 hpf after 
exposuring the embryos to 100 µM Au1.4MS. The string-like heart and the reduced 
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contraction strength together with the bradycardia most likely led to anoxia and 
deprivation of energy. Zebrafish is known to be anoxia-tolerant in the first 24 hours of 
their life and this tolerance declines with the developmental stage 131. This could 
partially explain why most of the malformations occurred after the segmentation 
period (24 hpf).  
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6. Summary 
Gold nanoparticles (AuNPs) are intensively investigated and large numbers of novel 
AuNPs are designed for in vivo applications. However, the impact of the AuNPs on 
the environment, organism and embryonic development are not clear and the critical 
parameters determing the safety of AuNPs are still under investigation. The toxicity of 
AuNPs is already known to depend on their size 31. In this study, the correlation 
between the ligand chemistry and nanotoxicity was investigated. The acute toxicity of 
different AuNPs was assessed by cell-based experiments including viability tests, 
death pathway investigations, oxidative stress measurements and gene expression 
analysis. Furthermore, the influence of AuNPs on the embryonic development was 
evaluated using zebrafish embryonic development tests. In addition, the potential 
cardiotoxicity of AuNPs was also evaluated by patch clamp experiments in hERG 
stably transfected HEK293 cells. All results consistently showed that, ultrasmall thiol 
modified AuNPs of 1.1-1.9 nm diameter (Au1.1GSH and Aurovist) were nontoxic in 
respect to acute, embryonic and cardiac toxicity while the triphenylphosphine 
monosulfonate (TPPMS) modified 1.4 nm AuNPs (Au1.4MS) elicited cell necrosis by 
progressively producing oxidative stress in HeLa cells, blocked the hERG channel in 
transfected cells, and induced malformation and embryonic death in zebrafish 
embryos. In accordance with the conclusion that Au1.4MS induced cell death by 
excessively impairing the redox balance, the cytotoxicity of Au1.4MS could be 
reduced by addition of reducing agents including glutathione, N-acetyl-L-cysteine and 
an excess of the AuNPs stabilizing ligand TPPMS.  
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Zusammenfassung 
Gold Nanopartikel (AuNPs) werden intensiv untersucht und eine grosse Anzahl 
neuer AuNPs werden für in vivo Anwendungen entwickelt. Die Auswirkungen der 
AuNPs auf die Umwelt, den Organismus und die Embryonalentwicklung sind nicht 
klar und die entscheidenden Parameter, welche mit der Sicherheit von AuNPs 
korrelieren, werden noch untersucht. Die Toxizität von AuNPs beruht 
bekanntermassen auf ihrer Grösse. In dieser Arbeit wurden die Korrelation zwischen 
der Ligandenchemie und der Nanotoxizität untersucht. Die akute Toxizität von 
unterschiedlichen AuNPs wurde mittels zell-basierten Experimenten, einschliesslich 
Viabilitätstests, Todeswegpfaduntersuchungen, Messungen von oxidativem Stress 
und Genexpressionsanalysen bestimmt. Zusasätzlich wurde die potentielle 
Kardiotoxizität von AuNPs mittels Patch Clamp Studien in humanen Ether-à-go-go 
(hERG) Kaliumkanal stabil transfizierten humanen embryonalen Nieren 293-Zellen 
(HEK293 Zellen) untersucht. Darüberhinaus wurde der Einfluss von AuNPs auf die 
Embryonalentwicklung mittels Zebrafischembryonen untersucht. Alle Ergebnisse 
haben übereinstimmend gezeigt, dass bei gleicher Grösse, die Thiol-modifizierten 
AuNPs (Au1.1GSH und Aurovist) nicht-toxisch waren im Vergleich zu akuter, 
kardialer und embryonaler Toxizität, während Triphenylphosphine Monosulfonat 
(TPPMS) modifizierte 1.4 nm AuNPs (Au1.4MS) Zell-Nekrose durch den ständig 
generierten oxidativen Stress in HeLa-Zellen auslösten, den hERG Kanal in stabil 
transfizierten HEK293-Zellen blockierten und embryonalen Tod in 
Zebrafischembryonen auslösten. In Übereinstimmung mit der Schlussfolgerung, dass 
Au1.4MS Zelltod auslösten durch Veränderung der Redox-Balance, konnte die 
Zytotoxizität von Au1.4MS durch die Zugabe von reduzierenden Agentien wie 
Glutathion, N-Acetyl-Cystein sowie durch einen Überschuss des die Nanopartikel 
stabilisierenden Liganden TPPMS reduziert werden. Als Reaktion auf Au1.4MS, 
wurde auch die embryonale Mortalität reduziert. Das TPPMS selbst war im Rahmen 
der in den Experimenten eingesetzten Konzentrationen nicht toxisch. 
Bibliography 
 
 
 
97 
Bibliography 
1. FDA, Nanotechnology Task Force Report (2007). 
2. EMEA, Reflection Paper on Nanotechnology-Based Medicinal Products for 
Human Use (2006 ). 
3. SCENIHR, The appropriateness of existing methodologies to assess the 
potential risks associated with engineered and adventitious products of 
nanotechnologies (2005). 
4. Schmid, G. Large Clusters and Colloids - Metals in the Embryonic State. 
Chemical Reviews 92, 1709-1727 (1992). 
5. Hammer, B. & Norskov, J.K. Why Gold Is the Noblest of All the Metals. Nature 
376, 238-240 (1995). 
6. Schmid, G. et al. Current and future applications of nanoclusters. Chemical 
Society Reviews 28, 179-185 (1999). 
7. Castro, T., Reifenberger, R., Choi, E. & Andres, R.P. Size-Dependent Melting 
Temperature of Individual Nanometer-Sized Metallic Clusters. Physical Review B 42, 
8548-8556 (1990). 
8. Haruta, M. et al. Low-Temperature Oxidation of Co over Gold Supported on 
Tio2, Alpha-Fe2o3, and Co3o4. Journal of Catalysis 144, 175-192 (1993). 
9. Zhou, X.C., Xu, W.L., Liu, G.K., Panda, D. & Chen, P. Size-Dependent 
Catalytic Activity and Dynamics of Gold Nanoparticles at the Single-Molecule Level. 
Journal of the American Chemical Society 132, 138-146 (2010). 
10. Schmid, G. & Corain, B. Nanoparticulated gold: Syntheses, structures, 
electronics, and reactivities. European Journal of Inorganic Chemistry, 3081-3098 
(2003). 
11. Schmid, G., Klein, N., Korste, L., Kreibig, U. & Schonauer, D. Large Transition-
Metal Clusters .6. Ligand-Exchange Reactions on Au55(Pph3)12cl6 - the Formation 
of a Water-Soluble Au55 Cluster. Polyhedron 7, 605-608 (1988). 
12. Pissuwan, D., Valenzuela, S.M. & Cortie, M.B. Therapeutic possibilities of 
plasmonically heated gold nanoparticles. Trends Biotechnol 24, 62-67 (2006). 
13. Sperling, R.A., Rivera Gil, P., Zhang, F., Zanella, M. & Parak, W.J. Biological 
applications of gold nanoparticles. Chem Soc Rev 37, 1896-1908 (2008). 
14. Felsenfeld, D.P., Choquet, D. & Sheetz, M.P. Ligand binding regulates the 
directed movement of beta1 integrins on fibroblasts. Nature 383, 438-440 (1996). 
Bibliography 
 
 
 
98 
15. Choi, M.R. et al. A cellular Trojan Horse for delivery of therapeutic 
nanoparticles into tumors. Nano Lett 7, 3759-3765 (2007). 
16. Giordano, R.J., Edwards, J.K., Tuder, R.M., Arap, W. & Pasqualini, R. 
Combinatorial ligand-directed lung targeting. Proc Am Thorac Soc 6, 411-415 (2009). 
17. Hainfeld, J.F., Slatkin, D.N., Focella, T.M. & Smilowitz, H.M. Gold 
nanoparticles: a new X-ray contrast agent. Br J Radiol 79, 248-253 (2006). 
18. Khandoga, A. et al. Ultrafine particles exert prothrombotic but not inflammatory 
effects on the hepatic microcirculation in healthy mice in vivo. Circulation 109, 1320-
1325 (2004). 
19. Delfino, R.J., Sioutas, C. & Malik, S. Potential role of ultrafine particles in 
associations between airborne particle mass and cardiovascular health. Environ 
Health Perspect 113, 934-946 (2005). 
20. Olivier, J.C. Drug transport to brain with targeted nanoparticles. NeuroRx 2, 
108-119 (2005). 
21. Veiseh, O. et al. Specific targeting of brain tumors with an optical/magnetic 
resonance imaging nanoprobe across the blood-brain barrier. Cancer Res 69, 6200-
6207 (2009). 
22. Sharma, H.S. et al. Chronic treatment with nanoparticles exacerbate 
hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain 
pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-
290/51. J Nanosci Nanotechnol 9, 5073-5090 (2009). 
23. Kreyling, W.G., Semmler, M. & Moller, W. Dosimetry and toxicology of ultrafine 
particles. J Aerosol Med 17, 140-152 (2004). 
24. Geiser, M. & Kreyling, W.G. Deposition and biokinetics of inhaled 
nanoparticles. Part Fibre Toxicol 7, 2. 
25. Oberdorster, G. Pulmonary deposition, clearance and effects of inhaled 
soluble and insoluble cadmium compounds. IARC Sci Publ, 189-204 (1992). 
26. Sun, X. et al. An assessment of the effects of shell cross-linked nanoparticle 
size, core composition, and surface PEGylation on in vivo biodistribution. 
Biomacromolecules 6, 2541-2554 (2005). 
27. Minchin, R. Nanomedicine: sizing up targets with nanoparticles. Nat 
Nanotechnol 3, 12-13 (2008). 
Bibliography 
 
 
 
99 
28. Balogh, L. et al. Significant effect of size on the in vivo biodistribution of gold 
composite nanodevices in mouse tumor models. Nanomedicine 3, 281-296 (2007). 
29. Bartneck, M. et al. Rapid Uptake of Gold Nanorods by Primary Human Blood 
Phagocytes and Immunomodulatory Effects of Surface Chemistry. ACS Nano. 
30. Plard, J.P. & Bazile, D. Comparison of the safety profiles of PLA(50) and 
Me.PEG-PLA(50) nanoparticles after single dose intravenous administration to rat. 
Colloids and Surfaces B-Biointerfaces 16, 173-183 (1999). 
31. Pan, Y. et al. Size-dependent cytotoxicity of gold nanoparticles. Small 3, 1941-
1949 (2007). 
32. Meier, P., Finch, A. & Evan, G. Apoptosis in development. Nature 407, 796-
801 (2000). 
33. Jacobson, M.D., Weil, M. & Raff, M.C. Programmed cell death in animal 
development. Cell 88, 347-354 (1997). 
34. Campisi, J., Kim, S.H., Lim, C.S. & Rubio, M. Cellular senescence, cancer and 
aging: the telomere connection. Exp Gerontol 36, 1619-1637 (2001). 
35. Reaper, P.M., di Fagagna, F. & Jackson, S.P. Activation of the DNA damage 
response by telomere attrition: a passage to cellular senescence. Cell Cycle 3, 543-
546 (2004). 
36. Shivapurkar, N., Reddy, J., Chaudhary, P.M. & Gazdar, A.F. Apoptosis and 
lung cancer: a review. J Cell Biochem 88, 885-898 (2003). 
37. Evan, G. & Littlewood, T. A matter of life and cell death. Science 281, 1317-
1322 (1998). 
38. Renehan, A.G., Booth, C. & Potten, C.S. What is apoptosis, and why is it 
important? Bmj 322, 1536-1538 (2001). 
39. Makin, G. & Hickman, J.A. Apoptosis and cancer chemotherapy. Cell Tissue 
Res 301, 143-152 (2000). 
40. Hardwick, J.M. Apoptosis in viral pathogenesis. Cell Death Differ 8, 109-110 
(2001). 
41. Bossy-Wetzel, E. & Green, D.R. Detection of apoptosis by annexin V labeling. 
Methods Enzymol 322, 15-18 (2000). 
42. Kerr, J.F., Wyllie, A.H. & Currie, A.R. Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-
257 (1972). 
Bibliography 
 
 
 
100 
43. Kressel, M. & Groscurth, P. Distinction of apoptotic and necrotic cell death by 
in situ labelling of fragmented DNA. Cell Tissue Res 278, 549-556 (1994). 
44. Kothakota, S. et al. Caspase-3-generated fragment of gelsolin: effector of 
morphological change in apoptosis. Science 278, 294-298 (1997). 
45. Elmore, S. Apoptosis: a review of programmed cell death. Toxicol Pathol 35, 
495-516 (2007). 
46. Hebert, M.J., Takano, T., Holthofer, H. & Brady, H.R. Sequential morphologic 
events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived 
eicosanoids. J Immunol 157, 3105-3115 (1996). 
47. Silva, M.T., do Vale, A. & dos Santos, N.M. Secondary necrosis in multicellular 
animals: an outcome of apoptosis with pathogenic implications. Apoptosis 13, 463-
482 (2008). 
48. Kroemer, G. et al. Classification of cell death: recommendations of the 
Nomenclature Committee on Cell Death. Cell Death Differ 12 Suppl 2, 1463-1467 
(2005). 
49. Krysko, D.V. et al. Macrophages use different internalization mechanisms to 
clear apoptotic and necrotic cells. Cell Death Differ 13, 2011-2022 (2006). 
50. Vayssier, M., Banzet, N., Francois, D., Bellmann, K. & Polla, B.S. Tobacco 
smoke induces both apoptosis and necrosis in mammalian cells: differential effects of 
HSP70. Am J Physiol 275, L771-779 (1998). 
51. Shi, Y. Apoptosome: the cellular engine for the activation of caspase-9. 
Structure 10, 285-288 (2002). 
52. Thornberry, N.A. et al. A novel heterodimeric cysteine protease is required for 
interleukin-1 beta processing in monocytes. Nature 356, 768-774 (1992). 
53. Riedl, S.J. & Shi, Y. Molecular mechanisms of caspase regulation during 
apoptosis. Nat Rev Mol Cell Biol 5, 897-907 (2004). 
54. Earnshaw, W.C., Martins, L.M. & Kaufmann, S.H. Mammalian caspases: 
structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 
68, 383-424 (1999). 
55. Nagata, S. Fas ligand-induced apoptosis. Annu Rev Genet 33, 29-55 (1999). 
56. Kuwano, K. et al. Essential roles of the Fas-Fas ligand pathway in the 
development of pulmonary fibrosis. J Clin Invest 104, 13-19 (1999). 
Bibliography 
 
 
 
101 
57. Johnstone, R.W., Frew, A.J. & Smyth, M.J. The TRAIL apoptotic pathway in 
cancer onset, progression and therapy. Nat Rev Cancer 8, 782-798 (2008). 
58. Graczyk, P.P. Caspase inhibitors as anti-inflammatory and antiapoptotic 
agents. Prog Med Chem 39, 1-72 (2002). 
59. Van Noorden, C.J. The history of Z-VAD-FMK, a tool for understanding the 
significance of caspase inhibition. Acta Histochem 103, 241-251 (2001). 
60. Swannie, H.C. & Kaye, S.B. Protein kinase C inhibitors. Curr Oncol Rep 4, 37-
46 (2002). 
61. Caballero-Benitez, A. & Moran, J. Caspase activation pathways induced by 
staurosporine and low potassium: role of caspase-2. J Neurosci Res 71, 383-396 
(2003). 
62. Chae, H.J. et al. Molecular mechanism of staurosporine-induced apoptosis in 
osteoblasts. Pharmacol Res 42, 373-381 (2000). 
63. Stepczynska, A. et al. Staurosporine and conventional anticancer drugs 
induce overlapping, yet distinct pathways of apoptosis and caspase activation. 
Oncogene 20, 1193-1202 (2001). 
64. Wyllie, A.H. Glucocorticoid-induced thymocyte apoptosis is associated with 
endogenous endonuclease activation. Nature 284, 555-556 (1980). 
65. Walker, P.R., Pandey, S. & Sikorska, M. Degradation of chromatin in apoptotic 
cells. Cell Death Differ 2, 97-104 (1995). 
66. Pandey, S., Walker, P.R. & Sikorska, M. Separate pools of endonuclease 
activity are responsible for internucleosomal and high molecular mass DNA 
fragmentation during apoptosis. Biochem Cell Biol 72, 625-629 (1994). 
67. Sakahira, H., Enari, M. & Nagata, S. Cleavage of CAD inhibitor in CAD 
activation and DNA degradation during apoptosis. Nature 391, 96-99 (1998). 
68. Schafer, K.A. The cell cycle: a review. Vet Pathol 35, 461-478 (1998). 
69. Bao, S. et al. ATR/ATM-mediated phosphorylation of human Rad17 is required 
for genotoxic stress responses. Nature 411, 969-974 (2001). 
70. Bartkova, J. et al. ATM activation in normal human tissues and testicular 
cancer. Cell Cycle 4, 838-845 (2005). 
71. Chun, J. et al. Phosphorylation of Cdc25C by pp90Rsk contributes to a G2 cell 
cycle arrest in Xenopus cycling egg extracts. Cell Cycle 4, 148-154 (2005). 
Bibliography 
 
 
 
102 
72. Perdiguero, E. & Nebreda, A.R. Regulation of Cdc25C activity during the 
meiotic G2/M transition. Cell Cycle 3, 733-737 (2004). 
73. Wang, R. et al. Regulation of Cdc25C by ERK-MAP kinases during the G2/M 
transition. Cell 128, 1119-1132 (2007). 
74. Watson, J.V., Chambers, S.H. & Smith, P.J. A pragmatic approach to the 
analysis of DNA histograms with a definable G1 peak. Cytometry 8, 1-8 (1987). 
75. Suzuki, T., Fujikura, K., Higashiyama, T. & Takata, K. DNA staining for 
fluorescence and laser confocal microscopy. J Histochem Cytochem 45, 49-53 
(1997). 
76. Moore, A., Donahue, C.J., Bauer, K.D. & Mather, J.P. Simultaneous 
measurement of cell cycle and apoptotic cell death. Methods Cell Biol 57, 265-278 
(1998). 
77. Bedner, E., Li, X., Gorczyca, W., Melamed, M.R. & Darzynkiewicz, Z. Analysis 
of apoptosis by laser scanning cytometry. Cytometry 35, 181-195 (1999). 
78. Beyer, T.A., Auf dem Keller, U., Braun, S., Schafer, M. & Werner, S. Roles 
and mechanisms of action of the Nrf2 transcription factor in skin morphogenesis, 
wound repair and skin cancer. Cell Death Differ 14, 1250-1254 (2007). 
79. Nguyen, T., Nioi, P. & Pickett, C.B. The Nrf2-antioxidant response element 
signaling pathway and its activation by oxidative stress. J Biol Chem 284, 13291-
13295 (2009). 
80. Schreck, R., Rieber, P. & Baeuerle, P.A. Reactive oxygen intermediates as 
apparently widely used messengers in the activation of the NF-kappa B transcription 
factor and HIV-1. Embo J 10, 2247-2258 (1991). 
81. Fialkow, L., Chan, C.K., Rotin, D., Grinstein, S. & Downey, G.P. Activation of 
the mitogen-activated protein kinase signaling pathway in neutrophils. Role of 
oxidants. J Biol Chem 269, 31234-31242 (1994). 
82. Nel, A., Xia, T., Madler, L. & Li, N. Toxic potential of materials at the nanolevel. 
Science 311, 622-627 (2006). 
83. Cooke, M.S., Evans, M.D., Dizdaroglu, M. & Lunec, J. Oxidative DNA damage: 
mechanisms, mutation, and disease. Faseb J 17, 1195-1214 (2003). 
84. Townsend, D.M., Tew, K.D. & Tapiero, H. The importance of glutathione in 
human disease. Biomed Pharmacother 57, 145-155 (2003). 
Bibliography 
 
 
 
103 
85. Ekshyyan, O. & Aw, T.Y. Decreased susceptibility of differentiated PC12 cells 
to oxidative challenge: relationship to cellular redox and expression of apoptotic 
protease activator factor-1. Cell Death Differ 12, 1066-1077 (2005). 
86. Pias, E.K. & Aw, T.Y. Early redox imbalance mediates hydroperoxide-induced 
apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ 9, 
1007-1016 (2002). 
87. Ottaviano, F.G., Handy, D.E. & Loscalzo, J. Redox regulation in the 
extracellular environment. Circ J 72, 1-16 (2008). 
88. Meister, A. & Anderson, M.E. Glutathione. Annu Rev Biochem 52, 711-760 
(1983). 
89. Roth, R.A. & Koshland, M.E. Role of disulfide interchange enzyme in 
immunoglobulin synthesis. Biochemistry 20, 6594-6599 (1981). 
90. Boyland, E. & Chasseaud, L.F. The role of glutathione and glutathione S-
transferases in mercapturic acid biosynthesis. Adv Enzymol Relat Areas Mol Biol 32, 
173-219 (1969). 
91. Chasseaud, L.F. The nature and distribution of enzymes catalyzing the 
conjugation of glutathione with foreign compounds. Drug Metab Rev 2, 185-220 
(1973). 
92. Weisiger, R.A., Pinkus, L.M. & Jakoby, W.B. Thiol S-methyltransferase: 
suggested role in detoxication of intestinal hydrogen sulfide. Biochem Pharmacol 29, 
2885-2887 (1980). 
93. Marmstal, E. & Mannervik, B. Purification, characterization and kinetic studies 
of glyoxalase I from rat liver. Biochim Biophys Acta 566, 362-370 (1979). 
94. Meister, A. Glutathione, ascorbate, and cellular protection. Cancer Res 54, 
1969s-1975s (1994). 
95. Cotter, M.A. et al. N-acetylcysteine protects melanocytes against oxidative 
stress/damage and delays onset of ultraviolet-induced melanoma in mice. Clin 
Cancer Res 13, 5952-5958 (2007). 
96. del Camino, D., Holmgren, M., Liu, Y. & Yellen, G. Blocker protection in the 
pore of a voltage-gated K+ channel and its structural implications. Nature 403, 321-
325 (2000). 
97. Sanguinetti, M.C. & Tristani-Firouzi, M. hERG potassium channels and cardiac 
arrhythmia. Nature 440, 463-469 (2006). 
Bibliography 
 
 
 
104 
98. Smith, P.L., Baukrowitz, T. & Yellen, G. The inward rectification mechanism of 
the HERG cardiac potassium channel. Nature 379, 833-836 (1996). 
99. Spector, P.S., Curran, M.E., Zou, A., Keating, M.T. & Sanguinetti, M.C. Fast 
inactivation causes rectification of the IKr channel. J Gen Physiol 107, 611-619 
(1996). 
100. Schonherr, R. & Heinemann, S.H. Molecular determinants for activation and 
inactivation of HERG, a human inward rectifier potassium channel. J Physiol 493 ( Pt 
3), 635-642 (1996). 
101. Joo, F. et al. Ligands for water-solubilizing organometallic compounds. 
Inorganic Syntheses, Vol 32 32, 1-45 (1998). 
102. Turkevich, J. A study of the nucleation and growth processes in the synthesis 
of colloidal gold. Discuss. Faraday. Soc 11, 55-75 (1951). 
103. Negishi, Y., Nobusada, K. & Tsukuda, T. Glutathione-protected gold clusters 
revisited: bridging the gap between gold(I)-thiolate complexes and thiolate-protected 
gold nanocrystals. J Am Chem Soc 127, 5261-5270 (2005). 
104. Kroemer, G. Mitochondrial implication in apoptosis. Towards an endosymbiont 
hypothesis of apoptosis evolution. Cell Death Differ 4, 443-456 (1997). 
105. Mosser, D.D. & Morimoto, R.I. Molecular chaperones and the stress of 
oncogenesis. Oncogene 23, 2907-2918 (2004). 
106. Amsterdam, A. et al. Identification of 315 genes essential for early zebrafish 
development. Proc Natl Acad Sci U S A 101, 12792-12797 (2004). 
107. Turner, M. et al. Selective oxidation with dioxygen by gold nanoparticle 
catalysts derived from 55-atom clusters. Nature 454, 981-983 (2008). 
108. Fortner, J.D. et al. C60 in water: nanocrystal formation and microbial 
response. Environ Sci Technol 39, 4307-4316 (2005). 
109. Pan, Y. et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by 
oxidative stress and mitochondrial damage. Small 5, 2067-2076 (2009). 
110. Ionita, P., Conte, M., Gilbert, B.C. & Chechik, V. Gold nanoparticle-initiated 
free radical oxidations and halogen abstractions. Org Biomol Chem 5, 3504-3509 
(2007). 
111. Salnikov, V., Lukyanenko, Y.O., Frederick, C.A., Lederer, W.J. & Lukyanenko, 
V. Probing the outer mitochondrial membrane in cardiac mitochondria with 
nanoparticles. Biophys J 92, 1058-1071 (2007). 
Bibliography 
 
 
 
105 
112. Fagian, M.M., Pereira-da-Silva, L., Martins, I.S. & Vercesi, A.E. Membrane 
protein thiol cross-linking associated with the permeabilization of the inner 
mitochondrial membrane by Ca2+ plus prooxidants. J Biol Chem 265, 19955-19960 
(1990). 
113. Petronilli, V. et al. The voltage sensor of the mitochondrial permeability 
transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of 
the gating potential by oxidants and its reversal by reducing agents. J Biol Chem 269, 
16638-16642 (1994). 
114. Chernyak, B.V. & Bernardi, P. The mitochondrial permeability transition pore is 
modulated by oxidative agents through both pyridine nucleotides and glutathione at 
two separate sites. Eur J Biochem 238, 623-630 (1996). 
115. Liu, Y. et al. Gold-cluster degradation by the transition of B-DNA into A-DNA 
and the formation of nanowires. Angew Chem Int Ed Engl 42, 2853-2857 (2003). 
116. Lemasters, J.J. et al. Role of mitochondrial inner membrane permeabilization 
in necrotic cell death, apoptosis, and autophagy. Antioxid Redox Signal 4, 769-781 
(2002). 
117. Ritchie, T.J. & Macdonald, S.J. The impact of aromatic ring count on 
compound developability--are too many aromatic rings a liability in drug design? Drug 
Discov Today 14, 1011-1020 (2009). 
118. Sudlow, G., Birkett, D.J. & Wade, D.N. Spectroscopic Techniques in Study of 
Protein-Binding - Fluorescence Technique for Evaluation of Albumin Binding and 
Displacement of Warfarin and Warfarin-Alcohol. Clinical and Experimental 
Pharmacology and Physiology 2, 129-140 (1975). 
119. Ganapathi, S.B., Kester, M. & Elmslie, K.S. State-dependent block of HERG 
potassium channels by R-roscovitine: implications for cancer therapy. Am J Physiol-
Cell Ph 296, C701-C710 (2009). 
120. Thomas, D., Gut, B., Wendt-Nordahl, G. & Kiehn, J. The antidepressant drug 
fluoxetine is an inhibitor of human ether-a-go-go-related gene (HERG) potassium 
channels. J Pharmacol Exp Ther 300, 543-548 (2002). 
121. Margulis, M. et al. Protein binding-dependent decreases in hERG channel 
blocker potency assessed by whole-cell voltage clamp in serum. J Cardiovasc 
Pharmacol 55, 368-376. 
Bibliography 
 
 
 
106 
122. Rawson, D.M., Zhang, T., Kalicharan, D. & Jongebloed, W.L. Field emission 
scanning electron microscopy and transmission electron microscopy studies of the 
chorion, plasma membrane and syncytial layers of the gastrula-stage embryo of the 
zebrafish Brachydanio rerio: a consideration of the structural and functional 
relationships with respect to cryoprotectant penetration. Aquaculture Research 31, 
325-336 (2000). 
123. Fouquet, B., Weinstein, B.M., Serluca, F.C. & Fishman, M.C. Vessel 
patterning in the embryo of the zebrafish: guidance by notochord. Dev Biol 183, 37-
48 (1997). 
124. Isogai, S., Horiguchi, M. & Weinstein, B.M. The vascular anatomy of the 
developing zebrafish: an atlas of embryonic and early larval development. Dev Biol 
230, 278-301 (2001). 
125. Asharani, P.V. et al. Impact of multi-walled carbon nanotubes on aquatic 
species. J Nanosci Nanotechnol 8, 3603-3609 (2008). 
126. King-Heiden, T.C. et al. Quantum dot nanotoxicity assessment using the 
zebrafish embryo. Environ Sci Technol 43, 1605-1611 (2009). 
127. Scholz, E.P. et al. Biophysical properties of zebrafish ether-a-go-go related 
gene potassium channels. Biochem Biophys Res Commun 381, 159-164 (2009). 
128. Milan, D.J., Peterson, T.A., Ruskin, J.N., Peterson, R.T. & MacRae, C.A. 
Drugs that induce repolarization abnormalities cause bradycardia in zebrafish. 
Circulation 107, 1355-1358 (2003). 
129. Hassel, D. et al. Deficient zebrafish ether-a-go-go-related gene channel gating 
causes short-QT syndrome in zebrafish reggae mutants. Circulation 117, 866-875 
(2008). 
130. Langheinrich, U., Vacun, G. & Wagner, T. Zebrafish embryos express an 
orthologue of HERG and are sensitive toward a range of QT-prolonging drugs 
inducing severe arrhythmia. Toxicol Appl Pharmacol 193, 370-382 (2003). 
131. Padilla, P.A. & Roth, M.B. Oxygen deprivation causes suspended animation in 
the zebrafish embryo. Proc Natl Acad Sci U S A 98, 7331-7335 (2001). 
Appendix 
 
 
 
107 
Appendix 
Table 3 Genes up-regulated in cells treated with Au1.4MS, but not in cells untreated or treated 
with Au15MS; fold change is the given for treatment with Au1.4nm for 12 hours (S12)  
 
symbol full name expression 
level in 
untreated 
cells (log2) 
fold 
change 
(S12) 
gene 
ontology 
(molecular 
function) 
Uniprot Link and References 
HSPA6 heat shock 
70kDa protein 6 
(HSP70B) 
3.8 378.5 ATP 
binding 
http://www.uniprot.org/uniprot/P17066 
 
CHAC1 ChaC, cation 
transport 
regulator 
homolog 1 
5.2 32.9 Protein 
binding 
http://www.uniprot.org/uniprot/Q9BUX1 
 
C16orf81 chromosome 
16 open 
reading frame 
81 
2.3 29.7   
LOC284561 hypothetical 
protein 
LOC284561 
4.4 28.7   
SESN2 sestrin 2 4.2 27.0 (BP) Cell 
cycle arrest 
http://www.uniprot.org/uniprot/P58004 
 
LOC344887 similar to 
NmrA-like 
family domain 
containing 1 
3.7 26.1   
HMOX1 heme 
oxygenase 
(decycling) 1 
10.7 23.7 Enzyme 
binding; 
heme 
binding; 
heme 
oxygenase 
activity; 
signal 
transducer 
activity 
http://www.uniprot.org/uniprot/P09601 
 
GEM GTP binding 
protein 
overexpressed 
in skeletal 
5.4 21.6 GTP 
binding; 
calmodulin 
binding 
http://www.uniprot.org/uniprot/P55040 
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muscle 
DNAJA4 DnaJ (Hsp40) 
homolog, 
subfamily A, 
member 4 
6.3 20.4 Heat shock 
protein 
binding; 
unfolded 
protein 
binding 
http://www.uniprot.org/uniprot/Q8WW22 
 
PGF placental 
growth factor, 
vascular 
endothelial 
growth factor-
related protein 
2.9 20.1 Growth 
factor 
activity; 
Heparin 
binding 
http://www.uniprot.org/uniprot/P49763 
 
PPP1R15A protein 
phosphatase 1, 
regulatory 
(inhibitor) 
subunit 15A 
5.2 16.4 Protein 
binding 
http://www.uniprot.org/uniprot/O75807 
 
LOC387763 hypothetical 
LOC387763 
4.0 14.8   
DDIT3 DNA-damage-
inducible 
transcript 3 
7.3 14.1 Protein 
dimerization 
activity; 
sequence-
specific 
DNA 
binding 
http://www.uniprot.org/uniprot/P35638 
 
HSPA1A heat shock 
70kDa protein 
1A 
12.5 12.56 Unfolded 
protein 
binding 
http://www.uniprot.org/uniprot/P08107 
 
IL8 interleukin 8 3.7 12.2 Chemokine 
activity 
http://www.uniprot.org/uniprot/P10145 
 
OSGIN1 oxidative stress 
induced growth 
inhibitor 1 
3.9 10.2 Growth 
factor 
activity 
http://www.uniprot.org/uniprot/Q9UJX0 
 
FOSL1 FOS-like 
antigen 1 
6.6 8.2 Protein 
dimerization 
activity; 
sequence-
specific 
DNA 
binding 
http://www.uniprot.org/uniprot/P15407 
 
NGFB nerve growth 6.0 5.13 Growth http://www.uniprot.org/uniprot/P01138 
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factor, beta 
polypeptide 
factor 
activity 
 
CXCL2 chemokine (C-
X-C motif) 
ligand 2 
6.0 3.7 Chemokine 
activity 
http://www.uniprot.org/uniprot/P19875 
 
GSTM3 glutathione S-
transferase M3 
5.7 2.1 Glutathione 
transferase 
activity; 
protein 
binding 
http://www.uniprot.org/uniprot/P21266 
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Table 4 Genes transiently up-regulated in all cells, regardless of treatment; fold change is 
given for treatment with Au1.4nm for 1 hour (S1) 
 
symbol full name expression 
level in 
untreated 
cells (log2) 
fold 
change 
(S1) 
gene ontology 
(molecular function) 
Uniprot Link and References 
EGR1 early growth 
response 1 
6.9 20.6 Transcription factor 
activity; zinc finger 
protein 
http://www.uniprot.org/uniprot/P18146 
 
FOS v-fos FBJ 
murine 
osteosarcoma 
viral 
oncogene 
homolog 
4.3 16.8 SMAD binding; 
Promoter binding; 
transcription factor 
activity 
http://www.uniprot.org/uniprot/P01100 
 
EDN1 endothelin 1 7.1 11.1 Endothelin A receptor; 
endothelin B receptor 
binding; hormone 
activity 
http://www.uniprot.org/uniprot/P05305 
 
CALD1 caldesmon 1 3.5 10.6 Actin binding; 
Calmodulin binding; 
Myosin binding; 
Tropomyosin binding 
http://www.uniprot.org/uniprot/Q05682 
 
DUSP5 dual 
specificity 
phosphatase 
5 
5.4 10.1 MAP kinase 
tyrosine/serine/threonine 
phosphatase activity 
http://www.uniprot.org/uniprot/Q16690 
 
ATF3 activating 
transcription 
factor 3 
7.2 9.8 Identical protein binding; 
protein dimerization 
activity; sequence 
specific DNA binding; 
transcription factor 
activity 
http://www.uniprot.org/uniprot/P18847 
 
NR4A1 nuclear 
receptor 
subfamily 4, 
group A, 
member 1 
7.1 8.8 Sequence-specific DNA 
binding; steroid 
hormone receptor 
activity; transcription 
factor activity; zinc ion 
binding 
http://www.uniprot.org/uniprot/P22736 
 
SERPINE1 serpin 
peptidase 
inhibitor, 
5.2 8.1 Protease binding; 
Serine-type 
endopeptidase activity; 
http://www.uniprot.org/uniprot/P05121 
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clade E 
(nexin, 
plasminogen 
activator 
inhibitor type 
1), member 1 
 
EMP1 epithelial 
membrane 
protein 1 
2.6 7.1  http://www.uniprot.org/uniprot/P54849 
 
PTGER4 prostaglandin 
E receptor 4 
(subtype 
EP4) 
9.0 6.0 Prostaglandin E 
receptor activity 
http://www.uniprot.org/uniprot/P35408 
 
EGR3 early growth 
response 3 
3.0 5.4 Transcription factor 
activity; zinc ion binding 
http://www.uniprot.org/uniprot/Q06889 
 
C5orf13 chromosome 
5 open 
reading frame 
13 
2.4 5.0   
DUSP2 dual 
specificity 
phosphatase 
2 
6.0 5.0 MAP kinase 
tyrosine/serine/threonine 
phosphatase activity; 
protein tyrosine 
phosphatase activity; 
protein 
tyrosine/threonine 
phosphatase activity 
http://www.uniprot.org/uniprot/Q05923 
 
NR4A3 nuclear 
receptor 
subfamily 4, 
group A, 
member 3 
5.9 4.6 Sequence-specific DNA 
binding; steroid 
hormone receptor 
activity; transcription 
factor activity; thyroid 
hormone receptor 
activity; zinc ion binding 
http://www.uniprot.org/uniprot/Q92570 
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Table 5-7 refer to Figure 26A 
Table 5 The number of live embryos in each well in the presence of Au1.4MS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
Au1.4MS live embryos 
0µM 24hpf 10 9 10 10 9 10 
0µM 48hpf 5 5 5 5 5 5 
0µM 72hpf 0 0 0 0 0 0 
 
50µM 24hpf 10 9 9 9 10 10 
50µM 48hpf 4 1 4 1 3 3 
50µM 72hpf 0 0 0 0 0 0 
 
100µM 24hpf 10 9 9 9 9 10 
100µM 48hpf 8 8 8 8 8 8 
100µM 72hpf 3 4 4 4 4 5 
 
200µM 24hpf 9 8 8 9 9 8 
200µM 48hpf 9 8 8 9 9 8 
200µM 72hpf 9 7 8 9 8 8 
 
400µM 24hpf 4 4 4 4 4 3 
400µM 48hpf 0 0 0 0 0 0 
400µM 72hpf 0 0 0 0 0 0 
 
Table 6 The number of dead embryos in each well in the presence of Au1.4MS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
Au1.4MS dead embryos 
0µM 24hpf 0 1 0 0 1 0 
0µM 48hpf 0 1 0 0 1 0 
0µM 72hpf 0 1 0 0 1 0 
 
50µM 24hpf 0 1 1 1 0 0 
50µM 48hpf 0 1 1 1 0 0 
50µM 72hpf 0 1 1 1 0 0 
 
100µM 24hpf 0 1 1 1 1 0 
100µM 48hpf 1 1 1 1 1 0 
100µM 72hpf 1 1 1 1 1 0 
 
200µM 24hpf 1 2 2 1 1 2 
200µM 48hpf 1 2 2 1 1 2 
200µM 72hpf 1 3 2 1 1 2 
 
400µM 24hpf 6 6 6 6 6 7 
400µM 48hpf 10 10 10 10 10 10 
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400µM 72hpf 10 10 10 10 10 10 
 
Table 7 The number of hatched larvae in each well in the presence of Au1.4MS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
Au1.4MS hatched larvae 
0µM 24hpf 0 0 0 0 0 0 
0µM 48hpf 5 4 5 5 4 5 
0µM 72hpf 10 9 10 10 9 10 
 
50µM 24hpf 0 0 0 0 0 0 
50µM 48hpf 6 8 5 8 7 7 
50µM 72hpf 10 9 9 9 10 10 
 
100µM 24hpf 0 0 0 0 0 0 
100µM 48hpf 1 1 1 1 1 2 
100µM 72hpf 6 5 5 5 5 5 
 
200µM 24hpf 0 0 0 0 0 0 
200µM 48hpf 0 0 0 0 0 0 
200µM 72hpf 0 0 0 0 1 0 
 
400µM 24hpf 0 0 0 0 0 0 
400µM 48hpf 0 0 0 0 0 0 
400µM 72hpf 0 0 0 0 0 0 
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Table 8-10 refer to Figure 26B 
Table 8 The number of live embryos in each well in the presence of the mixture containing 
Au1.4MS and glutathione. Ten embryos were dispensed in each well at the beginning of the 
experiment. 
Au1.4MS+GSH live embryos 
0µM 24hpf 10 9 10 10 9 10 
0µM 48hpf 5 5 5 5 5 5 
0µM 72hpf 0 0 0 0 0 0 
 
50µM 24hpf 10 10 10 10 10 10 
50µM 48hpf 7 7 5 6 6 5 
50µM 72hpf 0 1 0 0 0 1 
 
100µM 24hpf 10 10 10 10 10 10 
100µM 48hpf 7 6 6 6 6 6 
100µM 72hpf 1 0 0 0 0 1 
 
200µM 24hpf 10 10 10 9 10 10 
200µM 48hpf 2 6 0 9 1 1 
200µM 72hpf 1 0 0 1 1 0 
 
400µM 24hpf 10 8 8 8 10 9 
400µM 48hpf 8 0 4 4 5 5 
400µM 72hpf 2 0 1 1 1 1 
 
Table 9 The number of dead embryos in each well in the presence of the mixture containing 
Au1.4MS and glutathione. Ten embryos were dispensed in each well at the beginning of the 
experiment. 
Au1.4MS+GSH dead embryos 
0µM 24hpf 0 1 0 0 1 0 
0µM 48hpf 0 1 0 0 1 0 
0µM 72hpf 0 1 0 0 1 0 
 
50µM 24hpf 0 0 0 0 0 0 
50µM 48hpf 0 0 0 0 0 0 
50µM 72hpf 0 0 0 0 0 0 
 
100µM 24hpf 0 0 0 0 0 0 
100µM 48hpf 0 0 0 0 0 0 
100µM 72hpf 0 0 0 0 0 0 
 
200µM 24hpf 0 0 0 1 0 0 
200µM 48hpf 0 0 0 1 0 0 
200µM 72hpf 0 0 0 1 0 0 
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400µM 24hpf 0 2 2 2 0 1 
400µM 48hpf 0 2 2 2 0 1 
400µM 72hpf 0 2 2 2 0 1 
 
Table 10 The number of hatched larvae in each well in the presence of the mixture containing 
Au1.4MS and glutathione. Ten embryos were dispensed in each well at the beginning of the 
experiment. 
Au1.4MS+GSH hatched larvae 
0µM 24hpf 0 0 0 0 0 0 
0µM 48hpf 5 4 5 5 4 5 
0µM 72hpf 10 9 10 10 9 10 
 
50µM 24hpf 0 0 0 0 0 0 
50µM 48hpf 3 3 5 4 4 5 
50µM 72hpf 10 9 10 10 10 9 
 
100µM 24hpf 0 0 0 0 0 0 
100µM 48hpf 3 4 4 4 4 4 
100µM 72hpf 9 10 10 10 10 9 
 
200µM 24hpf 0 0 0 0 0 0 
200µM 48hpf 8 4 10 0 9 9 
200µM 72hpf 9 10 10 8 9 10 
 
400µM 24hpf 0 0 0 0 0 0 
400µM 48hpf 2 8 4 4 5 4 
400µM 72hpf 8 8 7 7 9 8 
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Table 11-13 refer to Figure 33B 
Table 11 The number of live embryos in each well in the presence of TPPMS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
TPPMS live embryos 
0µM 24hpf 10 9 10 10 9 10 
0µM 48hpf 5 5 5 5 5 5 
0µM 72hpf 0 0 0 0 0 0 
 
62.5µM 24hpf 9 10 9 9 9 10 
62.5µM 48hpf 9 10 9 9 9 9 
62.5µM 72hpf 3 2 2 2 2 3 
 
125µM 24hpf 9 10 10 10 10 9 
125µM 48hpf 9 10 9 9 9 9 
125µM 72hpf 3 1 0 0 2 1 
 
250µM 24hpf 9 10 10 10 10 8 
250µM 48hpf 9 10 9 8 10 8 
250µM 72hpf 3 1 1 1 1 4 
 
500µM 24hpf 9 9 10 8 8 10 
500µM 48hpf 9 9 7 8 8 10 
500µM 72hpf 4 1 1 1 1 1 
 
1000µM 24hpf 9 9 10 8 10 8 
1000µM 48hpf 9 9 9 8 9 8 
1000µM 72hpf 2 2 3 1 1 1 
 
Table 12 The number of dead embryos in each well in the presence of TPPMS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
TPPMS dead embryos 
0µM 24hpf 0 1 0 0 1 0 
0µM 48hpf 0 1 0 0 1 0 
0µM 72hpf 0 1 0 0 1 0 
 
62.5µM 24hpf 1 0 1 1 1 0 
62.5µM 48hpf 1 0 1 1 1 0 
62.5µM 72hpf 1 0 1 1 1 0 
 
125µM 24hpf 1 0 0 0 0 1 
125µM 48hpf 1 0 0 0 0 1 
125µM 72hpf 1 0 0 0 0 1 
 
250µM 24hpf 1 0 0 0 0 2 
250µM 48hpf 1 0 0 0 0 2 
250µM 72hpf 1 0 0 0 0 2 
 
500µM 24hpf 1 1 0 2 2 0 
500µM 48hpf 1 1 0 2 2 0 
500µM 72hpf 1 1 0 2 2 0 
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1000µM 24hpf 1 1 0 2 0 2 
1000µM 48hpf 1 1 0 2 0 2 
1000µM 72hpf 1 1 0 2 0 2 
 
Table 13 The number of hatched larvae in each well in the presence of TPPMS. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
TPPMS hatched larvae 
0µM 24hpf 0 0 0 0 0 0 
0µM 48hpf 5 4 5 5 4 5 
0µM 72hpf 10 9 10 10 9 10 
 
62.5µM 24hpf 0 0 0 0 0 0 
62.5µM 48hpf 0 0 0 0 0 1 
62.5µM 72hpf 6 8 7 7 7 7 
 
125µM 24hpf 0 0 0 0 0 0 
125µM 48hpf 0 0 1 1 1 0 
125µM 72hpf 6 9 10 10 8 8 
 
250µM 24hpf 0 0 0 0 0 0 
250µM 48hpf 0 0 1 2 0 0 
250µM 72hpf 6 9 9 9 9 4 
 
500µM 24hpf 0 0 0 0 0 0 
500µM 48hpf 0 0 3 0 0 0 
500µM 72hpf 5 8 9 7 7 9 
 
1000µM 24hpf 0 0 0 0 0 0 
1000µM 48hpf 0 0 1 0 1 0 
1000µM 72hpf 7 7 7 7 9 7 
 
Table 14-16 refer to Figure 33A 
Table 14 The number of live embryos in each well in the presence of glutathione. Ten embryos 
were dispensed in each well at the beginning of the experiment. 
GSH live embryos 
0µM 24hpf 10 9 10 10 9 10 
0µM 48hpf 5 5 5 5 5 5 
0µM 72hpf 0 0 0 0 0 0 
 
62.5µM 24hpf 10 10 9 10 10 10 
62.5µM 48hpf 6 7 6 5 8 8 
62.5µM 72hpf 1 0 0 0 0 1 
 
125µM 24hpf 8 10 9 9 9 9 
125µM 48hpf 5 8 5 5 5 5 
125µM 72hpf 0 0 0 0 0 0 
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250µM 24hpf 10 10 10 10 9 10 
250µM 48hpf 9 10 9 9 9 9 
250µM 72hpf 0 1 1 0 0 0 
 
500µM 24hpf 9 10 9 9 10 10 
500µM 48hpf 9 8 8 8 9 9 
500µM 72hpf 0 1 0 0 1 1 
 
1000µM 24hpf 5 6 4 5 5 6 
1000µM 48hpf 5 4 4 4 3 5 
1000µM 72hpf 1 0 0 0 1 0 
 
Table 15 The number of dead embryos in each well in the presence of glutathione. Ten 
embryos were dispensed in each well at the beginning of the experiment. 
GSH dead embryos 
0µM 24hpf 0 1 0 0 1 0 
0µM 48hpf 0 1 0 0 1 0 
0µM 72hpf 0 1 0 0 1 0 
 
62.5µM 24hpf 0 0 1 0 0 0 
62.5µM 48hpf 0 0 1 0 0 0 
62.5µM 72hpf 0 0 1 0 0 0 
 
125µM 24hpf 2 0 1 1 1 1 
125µM 48hpf 2 0 1 1 1 1 
125µM 72hpf 2 0 1 1 1 1 
 
250µM 24hpf 0 0 0 0 1 0 
250µM 48hpf 0 0 0 0 1 0 
250µM 72hpf 0 0 0 0 1 0 
 
500µM 24hpf 1 0 1 1 0 0 
500µM 48hpf 1 0 1 1 0 0 
500µM 72hpf 1 0 1 1 0 0 
       
1000µM 24hpf 5 4 6 5 5 4 
1000µM 48hpf 5 4 6 5 5 4 
1000µM 72hpf 5 4 6 5 5 4 
 
Table 16 The number of hatched embryos in each well in the presence of glutathione. Ten 
embryos were dispensed in each well at the beginning of the experiment. 
GSH hatched larvae 
0µM 24hpf 0 0 0 0 0 0 
0µM 48hpf 5 4 5 5 4 5 
0µM 72hpf 10 9 10 10 9 10 
 
62.5µM 24hpf 0 0 0 0 0 0 
62.5µM 48hpf 4 3 3 5 2 2 
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62.5µM 72hpf 9 10 9 10 10 9 
 
125µM 24hpf 0 0 0 0 0 0 
125µM 48hpf 3 2 4 4 4 4 
125µM 72hpf 8 10 9 9 9 9 
 
250µM 24hpf 0 0 0 0 0 0 
250µM 48hpf 1 0 1 1 0 1 
250µM 72hpf 10 9 9 10 9 10 
 
500µM 24hpf 0 0 0 0 0 0 
500µM 48hpf 0 2 1 1 1 1 
500µM 72hpf 9 9 9 9 9 9 
 
1000µM 24hpf 0 0 0 0 0 0 
1000µM 48hpf 0 2 0 1 2 1 
1000µM 72hpf 4 6 4 5 4 6 
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Abbreviations 
 
AAS    atomic absorption spectroscopy  
ANT    adenine nucleotide translocator  
AP-1              activator protein-1  
ATM              ataxia telangiectasia mutated  
ATP               adenosine triphosphate  
Au1.1GSH     glutathione modified 1.1 nm gold nanoparticles 
Au1.4MS       TPPMS modified 1.4 nm gold nanoparticles 
Au15MS        TPPMS modified 15 nm gold nanoparticles 
AuNPs           gold nanoparticles 
Au-SH            thiol modified gold nanoparticles 
B2H6               diborane 
bpm               beats per minute  
CaCl2             calcium chloride 
CAD               caspase-activated DNAse 
Cdc25C         cell division cycle 25C  
Cdk2              cyclin-dependent kinase 2  
cDNA             complementary DNA 
CFSE             carboxyfluorescein succinimidyl ester  
ChK2             checkpoint kinase 2 
CM-H2DCFDA     5-(and-6)-chloromethyl-2'7'- dichlorodihydrofluorescein diacetate  
cRNA   complementary ribonucleic acid 
ddH2O                 bidistilled water 
DEVD peptide     Asp-Glu-Val-Asp 
DF                       DMEM cell culture medium with 10% FBS 
DMEM                Dulbecco`s Modified Eagle Medium 1x  
DMSO                 dimethyl sulfoxide  
DNA                    deoxyribonucleic acid 
dpf                      days post fertilization 
E2                       zebrafish embryo egg water;  
EC                      patch clamp extracellular solution 
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ECG                   electrocardiography  
EGTA-KOH         ethylene glycol tetraacetic acid potassium hydroxide 
EMEA   European Medicines Agency  
ENM                   engineered nanomaterials 
FACS                  fluorescence activated cell sorting 
FBS                    fetal bovine serum  
FDA     Food and Drug Administration  
GSH                   reduced glutathione  
GSHPx               glutathione peroxidase  
GSSG                oxidized glugathione  
GST                   glutathione-S transferase  
H2O2                  hydrogen peroxide  
H2SO4                     sulfuric acid 
HAuCl4               chloroauric acid 
HCl                    hydrogen chloride  
HEK293             human embryonic kidney 293 cells 
HeLa                 human cervix carcinoma  
HEPES             4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
hERG                human ether-à-go-go  
hERG-HEK         hERG transfected HKE293 cell 
HMOX1             heme oxygenase-1  
hpf                hours post fertilization 
HTA              head-trunk angle  
IC50              the half maximal inhibitory concentration 
ICAD             inhibitor of caspase-activated DNAse  
ICP-AES       inductively coupled plasma atomic emission spectrometry  
ICP-MS         inductively coupled plasma mass spectrometry  
KCl               potassium chloride 
KH2PO4                monopotassium phosphate 
MAPK           mitogen-activated protein kinase  
MDM2          murine double minute  
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MgSO4          magnesium sulfate 
MPT             mitochondrial permeability transition  
mPTP           mitochondrial permeability transition pores  
MTT             thiazolyl blue tetrazolium bromide  
Na2HPO4        sodium phosphate 
NAA                neutron activation analysis 
NaBH4            sodium borohydride 
NAC               N-acetylcysteine  
NaCl              sodium chloride 
NaHCO3       sodium bicarbonate  
NF-kB          nuclear factor-kB  
NMR           nuclear magnetic resonance 
OSGIN1      oxidative stress induced growth inhibit  
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